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Abstract 
People living with heart failure (PLHF) should be screened for symptoms at every 
healthcare visit since they are 3 times more likely to experience ventricular arrhythmias. 
This quality improvement project (QIP) compared 3 self-administered HF symptoms 
questionnaires to determine the best screening tool for a tertiary hospital arrhythmia 
devices clinic. The instruments included the Minnesota Living with Heart Failure 
Questionnaire (MLHFQ), the Kansas City Cardiomyopathy Questionnaire (KCCQ), and 
the Self-Reported Heart Failure Symptoms (SHEFS) questionnaire. For a 30-day period, 
76 people were eligible to participate in the QIP, with 55 participants included in the final 
analysis (72.5% participation). The questionnaires were compared and assessed with the 
gold standard laboratory test for HF (NT-proBNP) for sensitivity and specificity. For HF, 
the SHEFS was the most sensitive (83%) compared to the NT-proBNP, but the MLHFQ 
was most specific (89%). When compared to the MLHFQ as the standard, SHEFS was 
71% sensitive, and 73% specific for HF. Similarly, when compared to the KCCQ, the 
SHEFS was both, 75% specific and sensitive in identifying HF.  However, the rate of 
correlation to a positive or negative NT-proBNP test results was the highest for the 
SHEFS (87%). All 3 questionnaires were statistically significant in predicting admission 
to hospital for HF in the past 6 months (p = 0.02 to 0.03). Finally, given the shortest 
length and simplicity of use, the SHEFS was selected by the stakeholders to be the 
standard screening tool for the clinic. This project contributes to positive social change by 
providing the first reported comparison in the literature to implement questionnaires in a 
clinic to assess symptoms for PLHF attending an arrhythmia devices clinic.  
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Section 1: Nature of the Project 
Introduction 
Heart failure is a chronic, progressive disease with unpredictable and fluctuating 
stages and cycles of exacerbation. According to Centers for Disease Control and 
Prevention (2016), there are close to 6 million adults in the United States living with 
heart failure. Approximately one in four heart failure patients die within one year and 
50% die within five years of initial diagnosis (Gerber et al., 2015). In the United States, 
approximately $40 billion is spent each year on caring for people living with heart failure 
(PLWHF) (Lloyd-Jones et al., 2010).  
The increased risk for life threatening cardiac arrhythmias is an important heart 
failure complication (van Riet et al., 2016). Arrhythmias result from the left ventricular 
dysfunction (LVD) diagnosed in the more than 40% of PLWHF (van Riet et al., 2016). 
The ventricular arrhythmias are highest amongst people with LVD accompanied by a low 
ejection fraction (EF) (40% or less) (Buxton et al., 2002). In this subgroup of patients, an 
implantable cardiac device (ICD) is recommended to prevent cardiac arrest from the 
ventricular arrhythmias (Bennett et al., 2016). With an ICD, PLWHF require routine 
monitoring and maintenance in a specialty arrhythmia devices clinic. The purpose of this 
quality improvement project was to identify an effective screening tool for self-reported 
symptoms of heart failure in order to efficiently recognize those who are at an increased 
risk of experiencing a cardiac arrest due to ventricular arrhythmia. 
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Problem Statement 
Local Context for Gap-in-Practice 
The Arrhythmia Devices Clinic (ADC) is an outpatient clinic, located in an 
ambulatory center of a large tertiary hospital in southwestern Ontario. The ADC is 
responsible for the continued care of PLWHF who have an ICD as a result of 
experiencing an episode of ventricular arrhythmia, or because they are at risk for 
developing an arrhythmia. Within the ADC, there is a robust quality management 
program focused on assurance, control, and improvement. The arrhythmia program 
database is an important source of information for the ADC quality management 
program, and which guided this project. 
At each cardiac related appointment, both the Heart Failure Society of America 
(HFSA), and the Canadian Cardiovascular Society (CCS) recommend a routine heart 
failure assessment for all people with history of heart failure or who are at risk for 
developing heart failure (Lindenfeld et al., 2010; Moe et al., 2015). This assessment 
includes review of signs and symptoms of heart failure such as orthopnea, paroxysmal 
nocturnal dyspnea, shortness of breath on exertion, and peripheral edema (Mayo Clinic, 
2017a). These assessments are especially important for people with a documented history 
of heart failure, and/or those who are at risk of developing heart failure (Lindenfeld et al., 
2010; Moe et al., 2015). Despite the importance of this assessment, practice in the ADC 
did not involve the element of evaluating patients for signs and symptoms of heart 
failure. As such, the missed opportunity to identify a patient at risk contributed to 
suboptimal care. 
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Local Relevance and Practice Environment 
A recent review of the arrhythmia program database revealed that close to 15% of 
patients who are being followed in the ADC are admitted, or readmitted to hospital 
annually with the diagnosis of heart failure or ventricular arrhythmias. As such, 
management of heart failure in the ADC was identified as one of the leading problems in 
need of addressing through a quality improvement project; an implementation of a heart 
failure screening tool. 
Although there are currently seven validated heart failure screening tools 
available in the literature (Dunderdale et al., 2008; Guyatt et al., 1989; Hak et al., 2004; 
Mannheimer et al., 2007; O’Leary et al., 2000; Spertus et al., 2015; Wiklund et al., 1987), 
none have been evaluated for use in an arrhythmia clinic setting (Garin et al., 2013; Garin 
et al., 2014) (Appendix A). As such, the validated tools needed to be evaluated for their 
sensitivity and specificity, as well as usability and usefulness, in identifying heart failure 
symptoms in arrhythmia clinic setting. 
Significance and Implications for Nursing Practice 
Given the compelling link between heart failure and arrhythmia, the need to 
identify an evidence-based screening tool for heart failure that is easy to use, and 
provides useful data in the arrhythmia clinic setting, was important to optimize patient 
care, and improve overall health outcomes. Nurses play an integral role in patient care 
and often represent the first and/or only encounter of the patient with the healthcare 
system. As such, optimization of care depends largely and completely on these 
opportunistic encounters. By implementing a heart failure screening instrument that is 
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feasible, suitable, and applicable to the ADC practice environment, would ensure that the 
nurses have the appropriate tools to optimize care, and improve patient outcomes. 
Purpose Statement and Project Objectives 
Gap-in-Practice Defined 
The purpose of this evidence-based quality improvement project, or EB-QIP, was 
to identify the most relevant heart failure screening instrument, evaluate the instrument 
validity, reliability, and applicability to the population, and then recommend the best 
instrument for the arrhythmia clinic. Previously, patients presenting to the ADC were not 
screened, assessed, and/or managed for heart failure. The project objective was to 
identify an evidence-based quality improvement tool that would increase health care 
provider’s awareness, knowledge, and use of evidence-based guidelines in the 
management of heart failure.  
Evidence-Based Practice 
Evidence-based health care combines current knowledge, up-to-date research, and 
expert advice in order to provide care that is consistent, effective, and efficient. Hanson et 
al. (2012) described how utilizing evidence-based guidelines in clinical practice led to a 
significant decrease in venous thromboembolic events in children after trauma. Similarly, 
a study done by Kudenchuk et al. (2012) showed how the use of evidence-based 
guidelines contributed to improved outcomes in patients who suffered an out of hospital 
arrest. Lastly, Farmakis et al. (2016) demonstrated how a substantial decrease in 
mortality from heart failure was achieved when evidence-based guidelines for heart 
failure were incorporated into the care process. 
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In order implement, promote, and ensure evidence-based practice, the research 
question to guide the practice must be first clearly defined. In this case, this was 
accomplished by utilizing the PICOT method: P (patient population/problem/place), I 
(intervention/test), C (comparison/current practice), O (outcomes), and T (type of 
project/time). Therefore, using the PICOT format, the research question was initially 
formulated as follows: In the population attending an outpatient ADC, which of three 
(two of which are evidence-based, and one of which was developed specifically for the 
project) self- administered heart failure symptoms instruments could best identify heart 
failure patients at risk for ventricular arrhythmia? The three instruments evaluated 
included: (a) Self-reported Heart Failure Symptoms (SHEFS) questionnaire (Appendix 
B), (b), Minnesota Living with Heart Failure Questionnaire (MLHFQ) (Appendix C), and 
(c) Kansas City Cardiomyopathy Questionnaire (KCCQ) (Appendix D). 
PICOT Process 
 In order to ensure the best patient outcomes, nurses need to incorporate the latest 
evidence in their clinical practice (Barth et al., 2016). This is an ongoing quality 
improvement process beginning with a structured question to define a clinical problem, 
called the PICOT question (Melnyk et al., 2011). This PICOT question is derived from a 
well described method to guide nurses in defining a clinical problem, organizing the facts 
into a clear and concise problem statement, identifying the best research evidence, and 
evaluating the evidence for implementation into practice. The evidence is evaluated to 
determine what interventions work the best, in what kind of clinical setting, and for what 
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patient population. This method informed the development of the PICOT question that 
guided this project. 
PICOT Question 
P-Patient/Population/Problem/Place 
Adult patients (age 18 or older) with a Cardiac Resynchronization Therapy-
Defibrillator (CRT-D) or a Cardiac Resynchronization Therapy-Pacemaker (CRT-P). 
Problem: There was no screening being done or documented for heart failure symptoms 
in patients attending the ADC. Existing screening questionnaires are complex and time 
consuming. Place: Outpatient, ambulatory ADC located in a tertiary hospital in 
southwestern Ontario 
I-Intervention  
The SHEFS instrument; the MLHFQ and the KCCQ instruments. 
C-Comparison 
Current standard, no instrument.  
O-Outcomes Measured  
The primary outcome for this project was the fit (or lack of fit) of the screening 
instruments for the clinical setting. Also, the sensitivity for identifying heart failure was 
evaluated. Secondary outcomes included a review of the rates of healthcare providers 
documenting the questionnaire findings in the patients’ charts. Finally, the rates of 
readmission to hospital with symptoms of heart failure and/or ventricular arrhythmias 
requiring shock from the device will be evaluated after the recommended screening tool 
has been implemented.  
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T-Type of Project/Time 
A quality improvement project with instrument evaluation. The quality 
improvement project was implemented over a period of one month. In addition, in order 
to evaluate the instrument's fit and suitability from a users’ perspective, the Delphi 
method was employed. 
Response to the Gap-in-Practice 
 The quality improvement project highlighted the need for healthcare providers to 
use evidence in the treatment of heart failure in the ADC setting. Secondly, by identifying 
and recommending a heart failure screening instrument that is most suitable for the ADC, 
this project represented the first step in changing practice behaviors. 
Nature of the Doctoral Project 
Project Sources of Evidence 
A recent review of the Planning and Analysis EP Database (unpublished, 
confidential ADC document) indicated that approximately 15% of readmissions to the 
hospital for patients with an implantable device are due to heart failure exacerbations, and 
heart failure related ventricular arrhythmias. The current practice in the ADC does not 
include screening, assessment, treatment, or documentation of patient’s signs and 
symptoms of heart failure.  
As PLWHF are at threefold the risk of developing ventricular arrhythmias, this 
was an important identified gap in practice that needed to be addressed (Cubbon et al., 
2016).  
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This quality improvement project proposed to establish a standardized operating 
procedure to effectively identify PLWHF seeking care at the ADC who are either at risk, 
or who are currently exhibiting heart failure signs and symptoms. The project endeavored 
to classify the existing heart failure screening tools as to their relevance, fit, applicability, 
and usability in this specialized clinical setting. Previously, there has been limited 
evidence as to the application of the existing heart failure screening tools within an 
outpatient clinic setting.  
Project Method 
Seven well-known and used instruments were identified in the literature; these 
were narrowed to the two most relevant for this project (Appendix A). Then, these two 
instruments were administered to measure the self-reported heart failure symptoms for 
the defined patient population. In addition, a new proposed heart failure screening tool 
developed especially for the clinic was administered alongside the validated tools for the 
purpose of comparison. Once this project data was collected and evaluated, a 
recommendation, as to the most appropriate tool, was presented to the stakeholders. Once 
the stakeholders selected an instrument, a policy and procedure with an education module 
will be developed to implement the instrument in the ADC.  
Project Pathway 
 The purpose of this doctoral project was to trial three different heart failure 
screening tools (two validated tools, and one newly developed tool) in the ADC setting, 
and identify the tool that would be most appropriate for being used in the clinic 
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environment. The best tool was then recommended for implementation in the care 
process. 
Significance of the Project 
Statistical Evidence  
With more than one million people hospitalized throughout the United States and 
Europe, heart failure is a global pandemic (Ambrosy et al., 2014). According to Dunay et 
al. (2014) about $70 billion will be spent annually on heart failure care by the year 2030. 
This expenditure can be reduced with wide spread implementation of the appropriate, 
relevant, and evidence based processes to aid in the early recognition and management of 
heart failure. For example, Farmakis et al. (2016) demonstrated how optimizing heart 
failure care through evidence-based recommendations significantly reduced morbidity 
and mortality from the disease.  
The progressive pathology of heart failure eventually leads to left ventricular 
dysfunction (Gerber et al., 2015), which results ultimately in electrical conduction 
abnormalities such as ventricular arrhythmias (van Riet et al., 2006). To treat these life-
threating conduction abnormalities, an implantable cardiac device is recommended 
(Beyerbach, 2016). Overall, early interventions can decrease the number and the severity 
of ventricular arrhythmias linked to the disease (Cubbon et al., 2016). 
Stakeholder Analysis  
The stakeholder analysis was important for this quality improvement project to 
identify all of the parties that could potentially affect or be affected by the project and/or 
project outcomes. (Hodges & Videto, 2011). The topic for this project was 
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collaboratively selected by the clinical director, medical director, clinical manager, and 
the project leader. Subsequently, additional stakeholders were identified and invited to 
participate in the development of the SHEFS questionnaire. The purpose behind the 
development of the SHEFS questionnaire, was to create a simple tool that would allow 
for a quick assessment of heart failure symptoms in the clinic setting, given the limited 
current resources. The additional stakeholders included arrhythmia physicians, clinical 
educator, nurse clinicians, clinical nurse specialist, cardio vascular technologists, and 
business clerks. Furthermore, the entire stakeholder group was invited to contribute to the 
project design and the implementation strategy. The project stakeholders were identified 
through personal conversations, program meetings’ discussions, and formal and informal 
electronic mail announcements.  
Stakeholders are considered to be those individuals that could affect or be affected 
by decisions, behaviors, or actions related to provision of care. This project embraced the 
involvement of the stakeholders as a critical source of knowledge specific to improving 
disease management. Kountz et al. (2015) argued that enhancements to patient care 
require a multidimensional approach, including the involvement of diversified 
stakeholders. Through an analysis, the authors found three main stakeholder groups: (a) 
patients, (b) healthcare providers, and (c) payers. For example, the study done by 
Haywood et al. (2014) demonstrated how health-related quality of life, and patient 
reported outcomes influenced, and were influenced by, the stakeholders: patients and the 
general public.  
Contributions to Nursing Practice  
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The purpose of the project was to create awareness among healthcare providers of 
the importance, relevance, and effects of evidence-based heart failure screening. 
Secondly, the project contributed to a meaningful modification of the arrhythmia clinic 
nurses’ attitudes, beliefs, and behavior patterns with respect to screening for heart failure, 
and generated practice that will include consistent use of evidence-based heart failure 
screening. Finally, the project enabled and supported the nurses in consistently applying 
evidence in their practice. 
Within the ADC setting, the role of nursing should encompass a routine 
interrogation of the implantable device, review and reconciliation of medications, vital 
signs measurement, and focused physical assessment of the patient. However, in majority 
of the cases, only the first two activities were completed (i.e. vital signs are not checked, 
and physical assessment is not performed). These omissions resulted in missed 
opportunities in identifying heart failure signs and symptoms. The nurses reported that 
time constraints, absence of management support, lack of knowledge of evidence-based 
guidelines, and overall lack of comfort in dealing with heart failure were the main 
barriers. However, as Saunders and Vehvilainen-Julkunen (2016) contended, nurses are 
optimally positioned to apply the best evidence to their clinical practice because of their 
skills, knowledge, experience, and nature of their roles. The nurses often represent the 
first, and sometimes the only healthcare encounter between the patient and healthcare 
agency. As such, nurses are best positioned to change practices and revise processes to 
optimize patient care. 
Transferability of Knowledge  
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Knowledge transfer is the process of sharing, communicating, spreading, or 
diffusing knowledge (theoretical or practical) to other individuals within the organization. 
The purpose of knowledge transfer is to ensure that all those involved have access to this 
knowledge of information, data, and results in order to establish full understanding of the 
issue(s) at hand, and to promote optimal collaboration. Singh et al. (2015) demonstrated 
how knowledge transfer approach resulted in an effective implementation and 
dissemination of best practice guidelines for stroke, and ultimately, in improved patient 
care and outcomes. The authors utilized a unit-based knowledge transfer team approach 
to champion and encourage the use of evidence-based guidelines through bedside 
mentoring, informal discussions, and collaborative patient care. 
Firstly, the knowledge developed by the stakeholders specific to quality 
improvement and evidence-based practice will be used for other projects within the ADC. 
Secondly, the knowledge obtained from the project implementation and evaluation has 
the potential of being applied in similar settings within the organization, as well as to 
other arrhythmia clinics in the region, province, and country. Finally, this knowledge will 
contribute to the development of new guidelines and protocols, and inform changes in 
practices. 
Implication for Positive Social Change  
Social change can be best described as any meaningful and considerable 
modification of behavior patterns, attitudes, and opinions, resulting in substantial social 
consequences or outcomes (Form & Wilterdink, 2017). For example, a systematic review 
and meta-analysis done by Laranjo et al. (2014) demonstrated that implementing 
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interventions through social networking sites resulted in significant positive effects on 
health behavior-related outcomes. 
Implementation of a feasible, applicable, and sustainable screening tool for heart 
failure symptoms in outpatient, ambulatory arrhythmia clinic patient population, will 
allow in the future for a consistent, comprehensive, and evidence-based assessment of 
patients for heart failure symptoms. This in turn will enable healthcare providers in early 
identification of the disease, initiation of appropriate interventions and follow up, and 
avoidance of hospital admission. Consequently, this will result in improved quality of life 
for the patient as well as a decrease in the risk of adverse events. 
Summary 
 In summary, heart failure care continues to contribute to a significant economic 
and psychosocial burden. The magnitude of the problem will likely continue to rise as the 
population ages, and more individuals are diagnosed with heart failure. One of the 
fundamental solutions to this problem, is to implement standardized, consistent, and 
evidence-based processes and methods to enable an early recognition of the disease and 
hence, an early treatment. A recent evaluation of the ADC environment revealed that no 
such screening was being done, and since a significant portion of ventricular arrhythmias 
is the direct result of heart failure, screening for symptoms of the disease should be an 
expected and integral component of clinic assessment.  
In the following section of this paper, an evidence-based practice model was 
defined, and the process of applying the model’s concepts to develop and implement 
interventions addressing the above issue, was described.  Background to the problem was 
14 
 
discussed within the context of the clinical setting, and the problem’s relevance to 
nursing practice was explained. Finally, the role of the project leader in this quality 
improvement project was explored, followed by a short synopsis of the research 
literature. 
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Section 2: Review of Scholarly Evidence 
Introduction 
Despite the fact that patients with heart failure are at higher risk of developing 
ventricular arrhythmias, previous practice in the ADC did not include the assessment of 
patients for signs and symptoms of heart failure (van Riet et al., 2016). As such, the 
purpose of this quality improvement project was to identify an effective screening tool 
for self-reported symptoms of heart failure in order to efficiently recognize those who are 
at an increased risk of experiencing a cardiac arrest due to ventricular arrhythmia. In this 
section of the paper, the evidence-based model used to guide this project will be 
described, the project’s relevance to nursing practice will be discussed, local background 
and context in which this project was developed will be examined, and the role of the 
DNP student will be outlined. 
Theories, Models, and Concepts 
According to Schaffer, Sandau, and Diedrick (2012), evidence-based practice 
(EBP) models assist in translating research evidence into clinical practice (Schaffer et 
al., 2012). Complexity of the practice problem as well as the nature of the clinical setting 
in which the problem is present will determine model suitability. Although there are a 
number of applicable EBP models available in the literature, the Stetler’s model of 
evidence-based practice guided this project (Stetler, 2001).  
Stetler Model of Research Utilization 
Since 1976, the Stetler model of evidence-based practice has been renamed the 
Stetler model of research utilization (Stetler, 1994). According to Stetler, this model is 
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based on the assumption that the individual’s use of research may or may not involve the 
formal organization and secondly, that lack of knowledge and skills related to the use of 
research can impede effectiveness of its use (National Collaborating Centre for Methods 
and Tools, 2011). 
The model also outlines some criteria to first establish if the project/program is 
desirable and feasible. These criteria include: level of corroborating evidence, current 
practice and magnitude of need for change, suitability for the project/program in the 
specific clinical setting, and the feasibility of implementing the program based on 
availability of human and financial resources, risks and benefits, and readiness of the 
stakeholders (Stetler, 2001).  
Stetler’s evidence-based practice model is comprised of five phases or stages to 
guide clinicians through the process of applying research findings in clinical practice. 
These phases include: (a) preparation, (b) validation, (c) comparative 
evaluation/decision making, (d) translation/application, and (e) evaluation. The Stetler’s 
model is appropriate for this quality improvement project as it mimics the five phases 
through: (a) preparation of the screening instruments, (b) validation of the instruments, 
(c) evaluation of suitability for the ADC, (d) application of results/knowledge, and (e) 
evaluation of outcomes. 
The first phase of the model includes identification of the problem at hand, 
exploring all influencing factors that may contribute to the issue, and evaluating 
available and current research on the topic. In the second phase of the model, the 
available evidence is evaluated for credibility and relevance to the stated problem. Third 
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phase of the model includes the process of summarizing research findings and 
formulating recommendations. Translation of evidence into practice, including the 
incorporation of any specific or required variations, makes up the fourth phase. In the 
fifth and final phase of the model, implementation outcomes are evaluated, and 
relevance to practice is outlined. The following paragraphs will describe how the 
model’s phases were completed throughout the Project. 
The first phase of Stetler’s model is designed to help the health care provider in 
identifying the need for change, or the need to solve a clinical problem, in the context of 
available and relevant evidence. In the case of the project, a review of the program’s 
2015 organizational data revealed that a significant portion of the ADC patients were 
readmitted to the hospital within 30 days of their device implantation. Majority of these 
readmissions were related to heart failure, and heart failure related ventricular 
arrhythmias. As part of quality improvement, the need to improve heart failure care 
within the clinic was identified. The specific characteristics of the clinic’s environment 
and staff were explored in order to assess any potential influencing factors that may 
influence or hinder implementation of practice change, such as lack or limited financial, 
physical, or human resources. 
In the second, or validation phase, each of the available sources of evidence were 
evaluated for credibility, relevance, and level of strength. The sources of evidence 
included program specific database, organizational statistics, peer hospitals, evidence-
based guideline depositories, and research literature. The relationship between heart 
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failure screening in the ADC, and the potential decrease in the rates of re-admissions for 
this patient population was established. 
The third phase of Stetler’s model involved the process of organizing the 
evidence, summarizing findings, and making recommendations. The result or end 
product of this phase was the recommendation that a screening tool for heart failure 
should be implemented within the ADC. The decision was made to trial three different 
tools: one developed specifically for the clinic, and two other tools that were previously 
applied in other settings. 
During the fourth, or translation phase of the model, the screening tools were 
evaluated as to their fit and applicability, and a formal plan for practice change was 
formulated. 
Finally, the fifth or evaluation phase of the model evaluated if proposed change 
was efficient and effective, and what type of strategies needed to be implemented in 
order for the change to be sustained. 
Project Relevance to Nursing Practice 
Search Strategy 
Literature search was conducted using the following databases: Cochrane 
Systematic Reviews, MEDLINE (PubMed), CINAHL, Psych Info, Google Scholar, and 
Embase. The key words included in the search were as follows: heart failure, guidelines, 
CRTs, outpatients, screening tools, ventricular arrhythmias, and self-reported (all MeSH 
terms). Only articles available in the English language were assessed and/or included in 
the literature review for the project. All abstracts yielded from the initial search were 
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reviewed before being considered for further examination and subsequent appraisal. 
Those articles deemed relevant to the project were included in the final analysis. 
Literature search was limited to articles from the year 2006 to 2016, unless they 
contributed to further knowledge and understanding of the issue at hand, such as original 
source articles. 
In total, 99619 articles were initially identified when the search terms heart 
failure and screening tools were used. The articles were narrowed down to 1495 when 
the above terms were used in combination with self-administered. These were further 
narrowed down to 132 articles when the term outpatients was added. Abstracts of all of 
the 132 articles were reviewed, and subsequently 12 articles were considered for the 
project’s literature review. Summary of the articles is presented in Appendix F with 
levels of evidence in Appendix G. 
General Literature 
There is ample evidence in the literature on the use of heart failure screening tools 
in inpatient settings (Garin et al., 2014; Green et al., 2000; Spertus et al., 2015) or in 
outpatient cardiology clinic settings (Eurich et al., 2006; Gilbert et al., 2015; Heidenreich 
et al. 2006; Masoudi et al., 2004). However, there is a limited evidence as to the use of 
the existing heart failure screening tools within an ambulatory arrhythmia clinic setting. 
The purpose of this project was to classify the existing heart failure screening 
tools/questionnaires as to their relevance, fit, applicability, and usability in the specialized 
clinical setting by the nursing staff. Since nurses represent the initial and most often the 
only contact of the arrhythmia patients with a healthcare provider during their clinic visit, 
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it is essential that screening for heart failure be completed by the nursing staff. Through 
their knowledge, skill, and expertise, and through the use of appropriate and relevant 
screening tool, nurses will be in a position to provide optimal patient care to the ADC 
patient population. 
 Heart failure is associated with a high morbidity and mortality rate with 
approximately 50% of individuals dying of the disease within five years of diagnosis, and 
25% dying within one year (Gerber et al., 2015). Those who were previously hospitalized 
for decompensated heart failure, are at significantly higher risk of recurrent events 
including death (Senni et al. 2014). Due to the frequent episodes of hospitalizations and 
re-hospitalizations required as a result of the disease, the economic burden of heart failure 
care is staggering. In 2012, the global annual cost of direct and indirect heart failure care 
was estimated to be nearly 108 billion dollars (Cook et al. 2014). In the United States 
specifically, this cost was assessed to be at over 30 million. In that same year, Canada 
spent close to four million on costs associated with heart failure.  
 The pathophysiology of heart failure contributes to left ventricular remodeling, 
which leads to abnormalities in the function and structure of the heart predisposing it to 
life-threatening arrhythmias (Jaeger, 2010). According to Jaeger, cardiac arrhythmias 
stemming from severe left ventricular dysfunction have the potential of resulting in 
sudden death. As a result, these patients most often have an implantable cardiac device 
inserted for primary prevention. In the case of ongoing heart failure symptoms and 
depressed left ventricular function, patients receive a device capable of cardiac 
resynchronization as well. Despite the available mechanical therapy, the goal of 
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optimizing heart failure, and decreasing the likelihood of ventricular arrhythmias, is to 
optimize medical therapy as per evidence-based guidelines. 
Specific Literature 
Guyatt (1993) argued that health-related quality of life could be measured 
through either a generic or a disease-specific instrument or both, as they are not 
mutually exclusive. The author described how each of these instruments has its strengths 
and weaknesses, and how one may be better over another depending on the setting 
and/or circumstances. Guyatt contended that the key measurement properties of an 
instrument were its ability to detect crucial changes (responsiveness), and its ability to 
measure what it was assumed to measure (validity). 
Berry and McMurray (1999) reviewed the design and validation of a number of 
general and disease-specific questionnaires, and their performance in measuring quality 
of life in patients with heart failure. The authors contended that in order for any 
questionnaire to be useful, it must be able to assess the patient’s physical, emotional as 
well as social status or wellbeing. Furthermore, disease-specific questionnaires, rather 
than generic questionnaires, provided more useful information when the effects of 
treatment were being measured. 
Similarly, Eurich et al. (2006) looked at the responsiveness of both generic and 
heart failure specific questionnaires to assess change over a period of six weeks. The 
responsiveness was measured in terms of psychometric indices as well as outside 
clinical data. The authors concluded that the Kansas City Cardiomyopathy Questionnaire 
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(KCCQ) was the most responsive tool when attempting to assess change over a short 
period of time. 
Garin et al. (2009) completed a systematic review with meta-analysis to evaluate 
heart failure specific quality of life instruments on their reliability, validity, and 
responsiveness. The following instruments were included in the review: Minnesota 
Living with Heart Failure Questionnaire (MLHFQ), Chronic Heart Failure 
Questionnaire (CHFQ), Quality of Life Questionnaire for Severe Heart Failure (QLQ-
SHF), Kansas City Cardiomyopathy Questionnaire (KCCQ), and Left Ventricular 
Dysfunction (LVD-36) questionnaire. Garin concluded that the evidence showed most 
support for the use of MLHFQ, followed by KCCQ, and then CHFQ.  
Then, five years later, Garin et al. (2014) conducted another systematic review to 
assess heart failure specific questionnaires. The authors identified seven such 
questionnaires, and evaluated them for reliability, validity, sensitivity to change, and 
interpretability. Overall, the authors rated the KCCQ as their first choice, followed by 
the MLHFQ, and the CHFQ. 
Finally, Kelkar et al. (2016) conducted a systematic review on the existing 
patient-reported outcomes tools for heart failure. Out of 31 instruments identified in the 
literature, nine met the authors’ initial inclusion criteria. Kelkar further assessed these 
nine instruments with respect to their psychometric indices and relevance to clinical 
practice. The authors concluded that only two out of the nine tools met all criteria: 
MLHFQ and the KCCQ.  
Evidence to Address the Gap-in-Practice 
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 Despite the overwhelming evidence in the literature that evidence-based 
guidelines contribute to an enhanced patient care and improved outcomes, guideline 
recommended therapies are often poorly followed by the healthcare providers. A 
systematic meta-analysis done by Gohler et al. (2006) reported that guideline suggested 
heart failure medications were prescribed by the providers on average 60% of the time 
and in as low as 10% of the cases. Although many studies in the literature define 
adherence as 80% compliance with recommended therapies, Vehovec et al. (2016) 
showed that rates higher than 80% were required to reduce the risk of death in heart 
failure patients. 
Local Background and Context  
Evidence to Justify the Problem 
A recent review of the planning and analysis EP Database (an unpublished and 
confidential document developed as part of a quality improvement project for the 
hospital) identified that about 15% of the AP patients are re-hospitalized within 30 days 
of having their implantable device inserted. Although a number of causes for the 
readmissions were identified, heart failure constituted to be the main reason, followed by 
episodes of ventricular arrhythmias. 
 By implementing best practice within the ADC, the arrhythmia program will 
contribute to providing the best care for its patients while advancing healthcare through 
education and research. Furthermore, improving heart failure care within the ADC, will 
likely result in decreased rates of readmission to hospital, and heart failure related 
complications.  
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Institutional Context 
The ADC is situated within a large tertiary hospital located in southwestern 
Ontario, Canada. The clinic is part of the arrhythmia program (AP) whose mandate is to 
provide assessment, treatment, and follow up care of patients with cardiac arrhythmias 
and/or, with implantable cardiac devices. As part of the Local Integrated Health 
Network, the AP is the regional referral center for patients with arrhythmias in 
southwestern Ontario. 
A Quality Improvement Plan (QIP) published by the hospital in 2014, identified 
five strategic organizational goals, including the need to implement best practices as the 
means to improve the patient experience (Hospital A, 2014). In response to the 
publication, the AP stakeholder team identified heart failure care as an area for 
improvement. The stakeholder team also acknowledged that any clinical project 
undertaken to meet the strategic goal, had to align with the mission, vision, and values of 
the organization. Through respect, caring, innovation, and accountability, the hospital’s 
mission is to “provide excellent health care for the people and communities we serve 
and to advance health care through education and research” (Hospital A, 2016). 
Local Terms and Definitions 
For the purpose of this project, the following terms were defined: 
Arrhythmia Devices Clinic (ADC) 
A specialized outpatient, ambulatory clinic providing care to patients who have an 
implantable cardiac device. 
Cardiac Resynchronization Therapy-Defibrillator (CRT-D)  
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An implantable medical device intended to synchronize the contractions of the 
ventricles for optimal efficiency of the heart (Boehmer, 2004; Marzec et al., 2017). It is 
also capable of delivering electrical energy through the heart when a ventricular 
arrhythmia is detected by the device (Ellenbogen et al., 2016). 
Cardiac Resynchronization Therapy-Pacemaker (CRT-P)  
An implantable medical device intended to synchronize the contractions of the 
ventricles for optimal efficiency of the heart (Boehmer, 2004; Marzec et al., 2017). It is 
also capable of electrically pacing the heart if the patient’s heart rate falls below 
predefined set parameters (Ellenbogen et al., 2016). 
Guidelines  
A set of evidence-based recommendations, developed by experts in the field, to 
guide care of a specified condition/disease including assessment, diagnosis, and treatment 
(National Institute for Health and Care Excellence, 2017). 
Heart Failure  
A condition in which the heart fails to keep up with the demands to provide 
adequate blood flow to the rest of the body (Heart and Stroke Foundation of Canada, 
2017). Most commonly associated with symptoms of shortness of breath, swelling of 
lower extremities, and inability to lie flat (American Heart Association, 2017). 
Stakeholders  
Any and all individuals who could influence or could be affected by the project’s 
implementation and outcomes (Hodges & Videto, 2011). 
Ventricular Arrhythmia  
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An abnormal rapid heart rhythm that originates in the lower chambers of the 
heart. This rhythm can result from damage to the heart muscle, cardiomyopathy, or 
sometimes in structurally normal hearts (Mayo Clinic, 2017b). Often associated with 
sudden cardiac death (Ellenbogen et al., 2016). 
Role of the DNP Student 
Professional Relationship to the Project 
The American Association of Colleges of Nursing (AACN) (2006), outlined the 
essentials, or critical elements, that are integral to define the role and responsibilities for 
graduates with the doctor of nursing practice (DNP). According to the AACN, a DNP 
program prepares students to meet these foundational elements. Subsequently, this 
project allowed the student to fulfill the requirements to successfully meet these 
essentials. Specifically, through this project the student was able to demonstrate the use 
of science to guide practice, incorporate organizational and systems leadership for 
quality improvement, analyze evidence, contribute to policy development, integrate 
inter-professional collaboration to improve patient outcomes, and influence population 
health (AACN, 2006). 
Professional Role in the Project 
In the context of this evidence-based quality improvement project, the DNP 
student functioned as the project leader, acting as a change agent within the healthcare 
agency. Specifically, the project leader was responsible for defining a clinical practice 
problem. Then, by designing, implementing, and evaluating an evidence-based quality 
improvement project, the project leader improved the clinical practice. The DNP student 
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had also the unique advantage of having the theoretical knowledge and the practical 
experience/expertise to bridge the gap between theory and practice, and to produce and 
introduce changes that would best serve the needs of the ADC population. 
Motivation for Completing the Project 
The DNP student’s motivation to complete this project stemmed from both a 
personal and professional desire to improve the treatment of heart failure patients at all 
levels of care. The student’s past work experience involved caring for patients in a heart 
failure specialty clinic. During this time period, many bonds were made between the 
student and the patient as well as the patient’s family members. The patients and their 
loved ones often referred to the clinic as their lifeline. However, only 2% of patients 
with the diagnosis of heart failure are actually followed in a specialty clinic (Howlett et 
al., 2015). The remaining 98% are followed by family practitioners, cardiologists, 
internists, or not at all. As such, the importance of identifying, treating, and optimizing 
heart failure at any cardiac related encounter, especially in ADC setting, was extremely 
high for the DNP student. By leading this change, the DNP student served as a role 
model and champion for the nursing profession by demonstrating commitment to 
evidence-based practice. Secondly, by implementing the DNP project, the student played 
a significant role in improving patient care, optimizing clinical outcomes, and improving 
efficiencies. Finally, the DNP student contributed to policy changes at all levels of care, 
by developing policies, and by planning, organizing, implementing, and evaluating new 
processes to improve delivery of care. This dedication to nursing profession and 
evidence-based practice was one of the strongest motivators to complete this project. On 
28 
 
a personal level, the DNP student’s motivation to complete the project was that of 
feeling of a personal accomplishment by reaching one of the student’s long-term life 
goals. 
Potential Biases 
 This DNP student had previously worked with heart failure population and was 
strongly motivated to improve the care of these patients in any setting. However, this 
motivation may have been interpreted as bias towards healthcare providers who did not 
think that heart failure assessment was important in the ADC setting. For example, 
resistance to change in practice may be interpreted as indifference or lack of knowledge 
rather than the fact that there are insufficient resources in place to sustain the change. 
 Another possible bias was the fact that the project included only patients who 
had a CRT-D or CRT-P device, as they have a known and documented history of heart 
failure (an initial indication for the implantable cardiac device). However, there may be 
other patients with an implantable cardiac device such as Permanent Pace Maker (PPM) 
or Implantable Cardioverter Defibrillator (ICD) who may exhibit initial or ongoing signs 
and symptoms of heart failure and who did not benefit from the assessment. 
Summary 
The purpose of this section was to explain and define the significance of the 
problem as it related to the clinical practice setting. This was accomplished by exploring 
the local background behind the problem and the context within which the problem 
exists. Secondly, the role of the DNP student in the project was explained and described 
as it pertained to the eight essentials for the DNP practice. Following that, a brief 
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literature review illustrated the scope of the problem and the need for change of the 
current practice. The literature also identified two screening tools for heart failure, which 
have been previously validated, and which were used for the purposes of the project: 
KCCQ and MLHFQ. Finally, the Stetler’s model for evidence-based practice was 
described in terms of the framework being chosen to support and guide the process of 
planning, developing, implementing, and evaluating the project. The next section of this 
paper will focus on outlining the study design, approach methods, data collection, and 
analysis of evidence.  
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Section 3: Collection and Analysis of Evidence 
Introduction 
Previous practice in the ADC did not include screening for the signs and 
symptoms of heart failure. This resulted in missed opportunities for optimization of care 
and potential, and avoidable, admissions to hospital due to heart failure, or ventricular 
arrhythmias due to exacerbation of the disease. The purpose of this evidence-based 
quality improvement project was to identify the most relevant heart failure screening 
instruments, evaluate the instrument validity, reliability, and applicability to the 
population, and recommend the best instrument for the arrhythmia clinic. A search of 
literature presented in the previous section, demonstrated that adherence to evidence 
based guidelines for heart failure is overall poor amongst healthcare providers (Gohler et 
al., 2006). Although the literature search yielded seven validated instruments for 
screening for heart failure, none have been evaluated in an arrhythmia clinic setting. 
In order to meet the project’s stated goals and objectives, a suitable and sound 
research methodology was applied, and data collection approaches identified. Both, 
methodology and study design, played instrumental roles in ensuring that the project met 
its stated goals and objectives. The method or approach to data collection depends on the 
type of data being collected, as well as the type of sources of data. For example, Hodges 
and Videto (2011) argued that information gathered for the purposes of program 
planning, should have both qualitative and quantitative components, and include primary 
and secondary sources.   The purpose of this chapter was to highlight the study 
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methodology, design, approaches to data collection, and strategies for analyzing the 
collected evidence.  
Practice-Focused Question 
 About 15% of this ADC patients are admitted or readmitted to hospital annually 
due to exacerbation of heart failure, and/or ventricular arrhythmias.  Despite these 
statistics, previous practice in the ADC did not include the screening for signs and 
symptoms of heart failure. As such, a simple, suitable, and reliable screening instrument 
was needed in the ADC in order to facilitate a change this practice. In ambulatory, 
outpatient arrhythmia devices clinic patient population, which of the three patient self-
administered heart failure symptoms questionnaires was the most suitable and feasible 
screening tool to be implemented in this specialized setting? 
Patient Population 
Adult patients with a Cardiac Resynchronization Therapy-Defibrillator (CRT-D) 
or a Cardiac Resynchronization Therapy-Pacemaker (CRT-P), who presented to the 
outpatient, ambulatory ADC located in a tertiary hospital in southwestern Ontario. 
Issue 
There was previously no screening being done or documented for heart failure 
symptoms in patients attending the ADC. Existing screening questionnaires were 
complex and time consuming.  
Intervention 
The main objective of the intervention was to compare the three questionnaires as 
means of establishing suitability and fit of the screening tools in this specialized setting. 
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Both the MLHFQ and the KCCQ have been previously validated as sensitive tools in 
screening for heart failure symptoms, and the SHEFS questionnaire was a new tool 
developed especially for the purposes of the clinic. 
Comparison 
No screening tools; previous practice. 
Outcomes Measured  
The primary outcome of this project measured the fit of the screening tool (or lack 
of fit) for the clinical setting as well as the sensitivity of the tool in identifying heart 
failure, as compared to the results of Brain Natriuretic Peptide (BNP) test—a specific 
blood test performed to establish presence/absence of heart failure. Two secondary 
outcomes have been subsequently identified one of which, was the evaluation of rates of 
compliance of the staff in documenting the questionnaires’ results in the patient chart. 
The final (secondary) outcome will look at evaluating the rates of readmission to the 
hospital with symptoms of heart failure and/or ventricular arrhythmias requiring shock 
from the device, after the screening tool has been implemented. Finally, a focus group 
comprised of the instrument users was asked to evaluate the tools’ fit and suitability for 
the practicum setting from their perspective, by using the Delphi technique. 
According to Rowe and Wright (2011) the description of the Delphi 
technique/method did not appear in print until 1975 although it has been developed by the 
Rand Corporation sometime in the 1950s. Although initially slow in being adopted by the 
wider audience, it has since gained popularity over the past couple of decades. It has been 
used in several fields of study, and by various disciplines as a method of soliciting the 
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opinions of experts to obtain an agreement or compromise on an issues or a topic. As Hsu 
and Sandford (2007) argued, it is “well suited as a means and method for consensus-
building” (p. 1). The traditional Delphi process involves four rounds of iterations (can 
vary anywhere from three to five) and employs the use of questionnaires as means of 
obtaining feedback. Each round of questionnaires asks the subjects to rate each item to 
establish priority or importance. However, as Goodman (2017) argued, this approach can 
sometimes create bias as subjects tend to rank/rate noncontroversial items higher than 
those that are controversial.  
Subject selection for the Delphi process is one of the most important aspects of 
this method as the quality of results is highly dependent on the expertise of the 
participants. In the case of this project, the three instruments were sent to the group of 
end-users who were asked to rate the questionnaires using a survey monkey program. 
Each individual in the group was asked to rate the questionnaires based on their 
perception as to the usability and fit of the tool in the clinical setting as well as their 
individual preference. Subsequently, the results were presented to the group at one of the 
program’s weekly meeting. Consensus was determined by majority of the individuals 
agreeing on one particular questionnaire as being the most suitable and preferable. 
Time 
The SHEFS questionnaire was administered in parallel to the MLFHQ, KCCQ, 
and BNP testing for a period of one month. The second secondary outcomes will be 
measured after six months of the best screening tool’s implementation. 
Project Purpose and Method Alignment 
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The purpose of this EB-QIP was to identify an effective screening tool for self-
reported symptoms of heart failure in order to efficiently recognize those who are at an 
increased risk of experiencing a cardiac arrest due to ventricular arrhythmia. By 
comparing a newly developed tool to two already validated heart failure screening tools, 
the project determined what tool was the most suitable for the arrhythmia clinic setting as 
a screening instrument. 
 Key Operational Definitions 
 Characteristics of interest. Screening tool’s ability to identify and recognize 
heart failure symptoms. 
 Measuring instrument. The measuring instruments were the three different self-
reported heart failure symptoms questionnaires. 
 Method of test. Three questionnaires, assembled in a random order, were 
administered to all consecutive patients meeting the pre-determined criteria. 
 Decision criteria. Each questionnaire’s score predicting a likelihood of heart 
failure, as compared to the other two questionnaires and to BNP results (if done), was 
deemed to be a sensitive tool for screening. 
 Statistical Package for the Social Sciences (SPSS), Version 19.0. A computer 
statistical software used to perform statistical analysis of the outcomes data.  
 Univariate regression analysis. A statistical method used to explore for a 
potential association between a single variable and a particular outcome of interest.    
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Sources of Evidence 
The possible sources of evidence were acquired from statistical data, evidence-
based guidelines for heart failure and best nursing practice (CCS, HFSA, AHA, RNAO 
guidelines), literature review, benchmarking to other like-organizations, existing hospital 
policies/procedures, stakeholder input, national clinical guidelines review, program 
specific databases, and evidence-based practice models. These sources of evidence 
helped in identifying the magnitude of the practice problem as compared to other-like 
organizations, the extent of use (or lack of use) of evidence based guidelines for heart 
failure in the arrhythmia clinic setting, as well as any currently available screening tools 
that have been previously validated.  
Archival and Operational Data 
 This doctoral project involved in part, an analysis of the organization’s 
operational data that is routinely collected as a component of its quality improvement 
measurement. Specifically, the rates of admission and readmission to hospital with the 
diagnosis of heart failure, amongst ADC patients, will be measured and compared 
between pre-implementation, and six-month post-implementation of the recommended 
screening tool. 
 The organization currently collects routine data on all hospital admissions 
including the cause for admission, and diagnosis at discharge. The EP program data 
analyst extracts the data that pertains specifically to the patients who are being followed 
in the ADC. The analysis is subsequently presented to the senior administration members 
of the program in database format.  
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Description of Data Collection 
 The data for this project was collected through a retrospective review of the 
patients’ health records with respect to the content and results of the questionnaires that 
were completed as part of the patient’s recent visit to the ADC. This included a review 
of the BNP blood results if they were completed. 
Participants 
 The parties that contributed evidence to address the practice-focused question 
were all those individuals who had completed the three questionnaires. As part of the 
EB-QIP, all patients who had either a CRT-P, or CRT-D were identified prior to their 
clinic visit, and subsequently asked to complete the questionnaires as part of their clinic 
visit. A participation of total of 50-60 patients was initially planned in order to provide 
meaningful data for analysis. 
Procedures 
 For this project, two existing and validated tools (KCCQ-12 and MLHFQ) were 
used to collect the evidence, along with a newly created tool (SHEFS questionnaire).  
 The KCCQ was initially developed by John Spertus and colleagues as a 23-item 
questionnaire to quantify “physical limitations, symptoms, self-efficacy, social 
interference and quality of life” in patient with congestive heart failure (Green et al, 
2000, p. 1245). The tool has been subsequently validated in a number of different 
conditions and settings (Joseph et al., 2013; Spertus et al., 2008; Tucker et al., 2016) 
The KCCQ was subsequently reduced by Spertus and Jones (2015) to a 12-item 
questionnaire (KCCQ-12) which demonstrated a preserved “validity, reliability, 
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responsiveness, prognostic importance, and interpretability of the original instrument” 
(Cardiovascular Outcomes Inc., 2016, p. 1). Spertus and Jones (2015) argued that the 
shorter version of the original KCCQ was more feasible to be implemented without 
compromising the psychometric properties of the original instrument. The KCCQ-12 
measures the reported frequency of symptoms, physical and social limitations, and 
alteration in quality of life because of heart failure. The score is calculated out of 70, and 
the lower the score, the worse are the predicted outcomes including highest risk for 
mortality and morbidity.  
 The MLHFQ was originally developed in 1984 at the University of Minnesota by 
Thomas Rector, as a self-administered method of measuring the effects of heart failure 
on an individual’s quality of life (Pietri et al., 2004). The tool has been since validated 
through several research studies for validity and reliability in various settings, under 
different conditions, and in different languages (Ahmeti et al., 2016; Bilbao et al., 2016; 
Garin et al., 2009; Supino et al., 2009) 
The questionnaire is composed of 21 questions, asking individuals to rate their 
heart failure symptoms, functional limitations, and psychological responses, on a scale 
from zero to five (zero representing no limitations, and five representing severe 
limitations). The maximum possible score is 105, with the lower score representing little 
or no effect on the individual’s quality of life, and higher score representing significant 
limitations to quality of life. 
 The SHEFS questionnaire was initially developed by the DNP student in 
conjunction with the medical director of the arrhythmia service. A draft of the 
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questionnaire was distributed to heart failure specialists in the organization for input and 
comments (as experts in the field) prior to finalization. The final format of the 
instrument is composed of five questions deemed by the heart failure experts to be the 
minimum elements required in the assessment for symptoms of heart failure. 
Analysis and Synthesis 
 The following paragraphs will outline this project’s approach with respect to 
project design and collection methods. Description of the study patient population will 
follow, containing details about inclusion and exclusion criteria. Finally, data collection 
methods will be explained followed by description of the evaluation plan.  
Data Systems and Procedures  
The project followed a prospective cohort design (Sedgwick, 2013). This type of 
design follows a group of similar individuals over a period of time. The patients with 
CRT-P or CRT-D device were identified the day prior to their clinic appointment and 
they were flagged for the study. The questionnaires were given to patients after they had 
registered and while awaiting clinic appointment. The package of questionnaires 
included a cover sheet (Appendix E) and the three questionnaires (SHEFS, KCCQ, and 
MLHFQ). The order of the questionnaires in the package was assigned a randomization 
sequence to prevent selection bias. The patients were asked to hand in their package to 
the healthcare provider that physically checked their device. Copies of the questionnaires 
were scanned into patient’s permanent electronic medical record, as per hospital policy 
for all documents pertaining to patient’s visit. These records were then accessed to 
review the completed questionnaires. The questionnaires were evaluated as to percentage 
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of completion, measured heart failure prognostic score, and their ability to successfully 
predict/identify heart failure as compared to the BNP results obtained during their clinic 
visit. All data was entered into an Excel spreadsheet, and subsequently exported to an 
SPSS (Version 19.0) program for analysis. 
Population and Sampling  
Inclusion criteria for the study was defined as adult patients (18 years or older) 
who presented to the ADC of the hospital, who had either a CRT-D or a CRT-P device 
in situ, and who were English speaking. Exclusion criteria was applied to patients who 
were less than 18 years of age, to those who did not have a CRT-D or a CRT-P device, 
who did not speak English, or those who refused to fill out the questionnaire. 
 Sampling method was defined as the inclusion of consecutive patients who met 
the above criteria, over a period of one month. 
Data Integrity  
The patients were asked to fill out the questionnaires while waiting for their 
appointment with the clinic staff. The questionnaires were then collected and results of 
each tool entered onto patient’s ADC electronic record. Copies of the questionnaires 
were then scanned (as per hospital’s protocol) to be included in permanent electronic 
record. Prior to scanning into the hospital record, the questionnaires were reviewed to 
ensure that they were correctly documented in the ADC’s electronic record. 
Subsequently, the questionnaire data was retrieved at a later date to perform secondary 
analysis. Any incomplete data was identified, recorded, and documented in the analysis. 
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Data Analysis  
The purpose of this quality improvement project was to assess for the most 
suitable and appropriate screening tool to be used in this clinical setting, in order to 
improve the management of heart failure in this patient population and subsequently, to 
decrease the rates of readmission for heart failure and heart failure-related ventricular 
arrhythmias.  As such, the primary outcome for this study was the performance of the 
three different questionnaires’ scores/results in their ability to predict or identify heart 
failure as compared to the bedside blood test for brain natriuretic peptide (BNP). For this 
project, both descriptive and inferential statistic were utilized to describe the basic 
features of the data elements, and to analyze the relationship(s) (if any) between the 
variables. 
The purpose of descriptive statistics is to provide/present a summary of the 
features of variables in the study, usually in the format of actual numbers (n), means, 
percentages, and distribution across quartiles. In this study, descriptive statistics were 
used to illustrate the quantitative characteristics of the data elements including age, 
gender, type of device (CRT-D or CRT-P), method of EF measurement, degree of left 
ventricular dysfunction, type of cardiomyopathy, previous history of heart failure, 
evidence of admission to hospital for heart failure in the past six months, and most 
responsible physician for heart failure care. 
Inferential statistics were used to determine if there was a difference between 
elements/groups, and if the observed difference was dependent rather than accidental. 
For this study, the three questionnaires were compared to the results of the BNP blood 
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test (as the gold standard) to determine a relationship (or lack of) between the 
questionnaires and the BNP. Secondly, the SHEFS questionnaire was compared to the 
MLHFQ and then to the KCCQ to determine if there was an association (a p-value of 
<0.05 was considered to show statistical significance). Finally, univariate regression 
analysis was performed to determine the association between the questionnaires’ scores, 
including the BNP results, and other elements such as admission to hospital in the past 
six months, NYHA functional class, medication class optimization, and ejection fraction.  
The final secondary outcomes will look at rates of readmission to hospital with 
symptoms of heart failure and/or ventricular arrhythmias requiring a shock from the 
device, after the recommended screening tool has been implemented.  
Project Evaluation Plan  
The evaluation plan had fourfold objective: to analyze and determine the 
sensitivity (or lack of) of the newly development SHEFS questionnaire in identifying 
heart failure as compared to the KCCQ, the MLHFQ, and the BNP, to determine which 
questionnaire was most suited for the ADC patient population given the current 
resources and environment, to determine the rates of compliance by staff in documenting 
results of the questionnaires, and to determine if rates of readmission to hospital with 
heart failure among this clinic’s patients has improved six months after implementing 
the recommended screening tool.  
Summary 
 In this section of the paper, the project question was outlined and stated in terms 
of patient population, intervention, control, observation, and time line. Subsequently, the 
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study design and methods were explained with respect to the method of data collection, 
type of participants, and mode of implementation procedures. Subsequently, the 
organization’s archival and operational data was identified as the main source of 
information required for project evaluation. In the following section, project findings and 
resultant recommendations will be presented and discussed. 
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Section 4: Findings and Recommendations 
Introduction 
 Despite the best available treatments, heart failure remains a major cause of 
morbidity and mortality worldwide. Half of the individuals diagnosed with heart failure 
will die within five years of the initial diagnosis, and one quarter will die within one year 
(Gerber et al., 2015). In 2012, the global economic burden of the direct and indirect costs 
associated with heart failure care were estimated at $108 billion for that year, and these 
costs will likely continue to rise as the population ages (Cook et al., 2014).  
Advanced or ongoing heart failure leads to a progressive left ventricular 
remodeling which subsequently contributes to abnormalities in the cardiac structure and 
function, resulting in the development of ventricular arrhythmias requiring treatment from 
an ICD. Despite the direct link between heart failure and ventricular arrhythmias, the 
ADC did not previously screen patients for symptoms of the disease. 
A recent review of the EP program database showed that close to 15% of the ADC 
patients are admitted and readmitted to hospital on annual basis with the diagnosis of 
heart failure and/or ventricular arrhythmias.  As a result of this data, the program’s 
executive team identified heart failure care as the priority for their program quality 
improvement initiative.  
Evaluation of existing practice identified that ADC nurses did not assess patients 
for heart failure. Given that heart failure and arrhythmia are inter-related, this poor 
approach to patient care acknowledged a significant gap in practice. As such, screening 
for heart failure symptoms within the ADC was identified as an area in need of 
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improvement. As a result, a quality improvement project was developed and designed to 
identify and determine the most appropriate, suitable, and feasible screening tool for heart 
failure in the ADC setting. The core of the practice-focused question was which self-
administered heart failure screening tool was most suitable in this specialty setting. 
Subsequently, two previously validated tools and one newly developed tool were 
administered to a select patient population within the ADC to evaluate their effectiveness 
in predicting heart failure. The purpose of this doctoral project was to evaluate all three 
tools and recommend the one that would be most appropriate in this clinical setting. 
Evidence for this project was obtained from the results of three self-administered 
questionnaires that were given to patients as part of their visit to the ADC. The 
questionnaires were initially administered as part of a quality improvement project to 
promote heart failure screening within the ADC. Subsequently, the information obtained 
from each of these questionnaires was accessed for analysis as to their predictive 
characteristics and feasibility of use in the ADC. An approval from the site’s Research 
Ethics Board (REB) (Appendix H) as well as the Walden University’s Institutional 
Review Board (IRB) (Appendix G) was obtained prior to implementation of the project. 
Findings and Implications 
Demographics and Descriptive Data 
 Over a period of one month, a total of 76 patients were identified for the study. 
Out of the total, 14 patients were identified as missed opportunity as they did not receive 
the package of questionnaires at the time of the clinic registration and therefore, were not 
included in the study. Out of the remaining 62 patients who did receive the package of 
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questionnaires, two did not speak English and therefore were unable to complete the 
questionnaires resulting in the two questionnaire packages being excluded from analysis. 
Subsequently, 60 questionnaire packages were analyzed. Questionnaire packages that 
were incomplete (either one or more of the questionnaires in the package was not 
completed) were also excluded, resulting in 55 patients being included in the final study 
analysis. 
 Of the 55 patients, 14 (25%) were female, and 41 (75%) were male. The average 
age of study patient was 69 years with a range between 41 and 85 years of age. Forty-
three (78%) of the 55 patients had previously documented history of heart failure, and 12 
(22%) did not. Approximately 10% of patients (n = 5) have had documented history of 
admission to hospital with heart failure in the past six months. 
 Distribution of patients with respect to device type, type of cardiomyopathy, New 
York Heart Association (NYHA) functional class, the degree of left ventricular (LV) 
dysfunction, and method of ejection fraction (EF) measurement is represented in Table 1 
(Distribution of patients), and the degree of LV function is represented in Table 2 (Left 
ventricular function). 
 
 
 
 
 
 
46 
 
Table 1 
Distribution of patients 
Variable    n   %  
Device type  
 CRT-P      9   16.4    
 CRT-D   46   83.6    
Type of cardiomyopathy 
 Ischemic   25   45.5    
 Non-ischemic   30   54.5    
NYHA class 
 I      3   5.5    
 II    21   38.2    
 III    19   34.5    
 IV      0   0 
 Not documented  12   21.8 
Degree of LV dysfunction 
 Normal     1     1.8    
 Mild    10   18.2 
 Moderate     7   12.7  
 Severe    34   61.8 
 Not documented    3     5.5   
Method of EF measurement 
 Echo    38   69.0 
 RNA      8   14.6  
 Angiogram     4     7.3 
 Not documented    5     9.1 
 
Table 2 
Left ventricular function  
    Ejection fraction % 
Normal   50% and > 
Mild dysfunction  40-50% 
Moderate dysfunction  30-49% 
Severe dysfunction  <30% 
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 The study patients reported that the most responsible physicians (MRPs) for their 
heart failure care were as follows: general practitioner (n = 6, 11%), cardiologist (n = 47, 
75%), internist (n = 1, 2%), and heart function clinic specialist (n = 1, 2%). 
 With respect to heart failure medications, the CCS (2015) recommends that three 
main classes of medications be prescribed for patients with the disease: angiotensin-
converting enzyme inhibitors (ACEIs), beta blockers (BBs), and mineralocorticoid 
receptor antagonists (MRAs). Out of the 55 study patients, 45 (82%) were on some type 
of ACEI, 50 (91%) were on a BB, and only 24 (44%) were on MRA. Only 20 (36%) were 
on all three recommended medications, and merely one individual was on optimal doses 
of all three classes of recommended medications. 
Results for the Heart Failure Screening Tools  
 Because heart failure is a collection of signs and symptoms, none of the 
questionnaires could confidently predict heart failure based on one measurement alone. 
As such, the diagnosis of heart failure could only be stated as “likely” or “unlikely.” 
 The average KCCQ score was 51.1, ranging from 27 to 67, with a score of 35 of 
less corresponding to “likely” heart failure (Green et al., 2008). Eight patients (14.5%) 
met the criteria of “likely” having heart failure i.e. scoring 35 or less on the questionnaire. 
 The average MLHFQ score was 24.5 with a range of 0 to 68, with a score of 53 or 
greater corresponding to patients “likely” having heart failure (Rector et al., 1987). Seven 
patients (13%) met the criteria of “likely” having heart failure (i.e. scoring 53 or greater 
on the questionnaire). 
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 The average SHEFS questionnaire score was 0.5, ranging from 0 to 5, with a score 
of 1 or greater corresponding to “likely” heart failure. Therefore, as per this criterion, 18 
patients (32.7%) “likely” had heart failure.  
 The average NT-proBNP (BNP) result was 1216, with a range between 62-3556 
pg/ml. Approximately 30% of the study patients (n = 15) had BNP test completed. Out of 
these patients, 6 (40%) “likely” had heart failure. Confirmation of heart failure was based 
on the BNP reference range presented in Table 3 (Mangla, 2014).  
Table 3 
Brain-type natriuretic peptide (BNP) reference range 
Heart failure unlikely   Heart failure likely 
<300 pg/ml     age <50 years, NT-proBNP >450 pg/ml 
      age 50-75 years, NT-proBNP >900 pg/ml 
      age >75 years, NT-proBNP >1800 pg/ml  
 
 In the 15 study patients who had NT-proBNP blood test completed, 13 (87%) of 
the results (heart failure likely or heart failure unlikely) corresponded to the SHEFS 
results, as compared to 11 (73%) corresponding to the MLHFQ results, and 11 (73%) 
corresponding to the KCCQ results. Of the 15 study patients who had all of the four test 
results available (NT-proBNP, SHEFS questionnaire, MLHFQ, and KCCQ) 10 (67%) 
were all in agreement with respect to heart failure being “likely” or being “unlikely.”  
 Comparison within the group of three (SHEFS questionnaire, MLHFQ, and 
KCCQ) showed that SHEFS matched the MLHFQ results 72% (n = 40) of the time, and 
the KCCQ 75% (n = 41) of the time.  MLHFQ results matched the KCCQ results 87% (n 
= 48) of the time. Comparison within the four groups is presented in Appendix J.   
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 All three questionnaires identified symptoms of heart failure. However, both the 
KCCQ and the MLHFQ took considerably longer to complete as they were composed of 
12 and 21 questions respectively, as compared to SHEFS questionnaire, which had only 
five questions. Secondly, both the KCCQ and the MLHFQ had a larger scale (1-7 and 0-5 
respectively) of rating which could result in under or over reporting of symptom severity. 
SHEFS questionnaire on the other hand, required only YES/NO answers and the 
questions were easy to understand.  
 With regards to the domains measured, both the KCCQ and the MLHFQ 
measured elements in the physical and emotional domains whereas the SHEFS 
questionnaire focused entirely on measuring physical symptoms.  
Finally, the SHEFS questionnaire had the higher rates of agreement with the NT-
proBNP results for presence or absence of heart failure than either the KCCQ or the 
MLHFQ. When comparing the SHEFS questionnaire, the MLHFQ, and the KCCQ to the 
NT-proBNP results, SHEFS had the highest percentage of sensitivity and it was as 
specific as the KCCQ but less specific than the MLHFQ. When comparing the SHEFS 
questionnaire to both the MLHFQ, and the KCCQ individually, the SHEFS had similar 
percentage of sensitivity and specificity for both groups.  
Documentation and Follow up Results  
 With respect to the health care providers (HCP) reviewing questionnaires with the 
patient, only 40 (73%) commented that they reviewed the results. Two of the 40 
questionnaires reviewed by the HCPs resulted in a referral to a heart function clinic, four 
in a referral to the Nurse Practitioner (NP), six in a referral to the MRP, and 27 in no 
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action taken. None of the patient charts showed evidence of documentation that the 
questionnaires were completed or reviewed, what the results of the questionnaires were, 
or what was the follow up of positive results. 
Unanticipated Limitations or Outcomes and Their Potential Impact on the Findings 
 One of the major limitations of the project that may have a potential impact on the 
findings was the fact that only 15 (27%) patients had NT-proBNP blood tests done. This 
test is very expensive to perform and only a select group of patients have it completed. 
The decision to have the NT-proBNP done or not is made by the MRP at the time of 
patient encounter, and it is based on a number of factors such as the patient’s condition at 
the time, patient’s past health history, presence of other comorbid diseases that may mask 
heart failure, and/or the MRP’s clinical judgment. 
 Another unanticipated limitation that may have a potential impact on the findings 
was the fact that both the organization and the ADC are currently undergoing many 
operational and system changes including changes in staffing complements and staffing 
models. The arrhythmia program’s previous all registered nurse (RN) model has shifted 
recently to a majority cardiovascular technologist (CVT) model. The two roles have 
different job descriptions, different scopes of practice, different practice standards, and 
different level of knowledge. Hence, the emphasis on physical assessment may be lower 
among the CVTs. Secondly, their level of understanding of the implications of positive 
screening findings may differ significantly. This may contribute to under reporting of 
patient symptoms and subsequently, to under- identify of these patients for further follow 
up.   
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Ethical, Legal, and Economic Implications 
 Within the ethical context, screening of all appropriate patients for heart failure 
ensures that patients are receiving fair, equal, and equitable care and services, which falls 
within the ethical principal of justice. Self-reporting of symptoms also allows for a degree 
of autonomy and self-determination whereas patients may choose to under or over report 
their symptoms or choose not to fill out the questionnaire at all. Implementing the heart 
failure screening tool within the ADC setting is also beneficent and non-maleficent, as 
there is a clear benefit of screening all appropriate patients for heart failure, and it does 
not cause harm. 
 From legal perspective, the questionnaire is not mandatory and therefore patients 
are not legally obligated to complete it. However, if and when patients complete the 
questionnaire/screening tool, it becomes a legal part of their medical record which is 
protected by privacy laws. Therefore, there are minimal legal implications for this project. 
 Within the economic context, implementing a heart failure screening tool will 
result in better heart failure management in the ADC. Early symptom identification may 
delay or completely avoid an admission to hospital with heart failure, resulting in 
substantial direct and indirect cost savings. Implementation of the tool itself, will require 
minimal resources as it is self-administered. 
Implications in Terms of Individuals, Communities, Institutions, and Systems 
The implications resulting from the project findings have multi-level effects. In 
terms of individuals, the findings showed that close to half of the ADC patient population 
was experiencing one or more symptoms of heart failure at the time of their clinic visit. 
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Without a screening tool, these patients would be potentially not identified and/or missed 
to follow up. This could subsequently result in these patients requiring an unplanned 
admission to hospital with heart failure, or in these patients experiencing a decreased 
quality of life because of their symptoms. 
From the community perspective, the ADC provides expert care to all patients 
living within its local integrated health network—a geographically defined regional area. 
As such, it has the obligation to ensure that it is providing the best care to all of its 
members within the region. The best care includes a comprehensive management of heart 
failure in those who have a history of the disease, as well as those who are at risk for 
developing the disease. 
From institution point of view, the implication of not implementing any screening 
tool at all creates the risk that the current practice will continue to maintain poor 
standards of care, and fail to meet professional practice standards. This approach will also 
contribute to underutilization of best evidence, research, and expert knowledge. 
 Documentation of findings and follow up on positive screening results is crucial 
to the success of the project (i.e. why screen if nothing is going to be done about the 
results?). In fact, the next step of this project is to develop a policy and procedure on how 
to deal with positive findings. 
Finally, from the systems perspective, the implication resulting from the project 
findings is that it will require an involvement and a coordinated effort between all 
members of the ADC staff to make this change a success. For example, the business 
clerks must supply all ADC patients with the questionnaire at the time of registration, the 
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CVTs and RNs must review and document the results of the screening tool as well as 
refer for appropriate follow up, and the NP and/or the MRP must ensure that an 
appropriate heart failure management is initiated. Finally, the manager of the clinic as 
well as the program director must support and enforce these activities, and the educator 
must be available as a resource for heart failure education. 
Implication to Positive Social Change 
 Within the social context, the project findings have the potential of bringing about 
a positive social change not only within the culture of the clinic itself, but also within the 
organization, and overall in the nursing profession. By changing behaviors, attitudes, 
values, patterns, and norms, the project findings will likely challenge, drive, modify and 
adjust current structures and arrangements. 
 From the ADC staff perspective, the findings will conceivably result in a change 
of the individual member’s values, beliefs, and opinions with respect to the significance 
and importance of screening for heart failure. The recommended interventions will also 
potentially change the staff members’ previous habits, behaviors, and practice routines. 
This in turn will both, generate and facilitate better patient care and, improve health 
outcomes. 
 From the organizational and systems perspective, the project findings will likely 
force a change in the existing policies and procedures with respect to management of 
heart failure in the ADC. By establishing and applying practice standards that meet the 
requirements of the profession, and ensuring that the latest research is incorporated in the 
organization’s policies and procedures, will lead to positive social change. 
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 Finally, from the nursing profession perspective, the project findings will lead to 
improved patient care by nurses in other like-settings. For example, by effectively and 
efficiently identifying those who are at risk, the screening tool can be implemented by 
other nurses in family practice settings, in cardiology outpatient offices, or in any other 
outpatient clinics. 
Recommendations 
The SHEFS questionnaire met the basic requirements for screening for heart 
failure in the ADC population: quick to complete, easy to understand and answer, able to 
identify the main physical symptoms of heart failure, and shown to be more predictive of 
heart failure in this setting as compared to the previously validated heart failure screening 
tools (KCCQ and MLHFQ). Secondly, when compared to the other two heart failure 
screening tools, the SHEFS questionnaire was determined by the end users to be a more 
suitable screening tool for this patient population. As such, the first recommendation is to 
implement the SHEFS questionnaire as the tool of choice for heart failure screening in the 
ADC.  
 The second recommendation is to ensure that heart failure screening is a 
mandatory and standard element of patient’s medical record completed by the staff during 
a patient visit to the ADC. This approach will ensure that all patients, regardless of the 
type of device or risk factors, are appropriately assessed, identified, and referred for 
further appropriate heart failure care. Development of organizational policy and 
procedure for this new practice would be highly recommended to prevent missed 
opportunities and avoided complications of heart failure and/or admission to hospital. 
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 The third recommendation is to mandate that an appropriate education on heart 
failure be completed by each of the staff as part of their orientation to the clinic. Being 
able to recognize not only the importance of screening for heart failure in this particular 
patient population, but also the most common signs and symptoms, would assist the 
HCPs in identifying those who are at risk and subsequently, intervening and/or 
implementing appropriate therapies. 
The fourth recommendation is to implement an appropriate and concrete 
documentation tool that would promote and encourage heart failure screening in the 
ADC. Currently, the rudimentary, and very basic, documentation process is not user 
friendly, includes only the health care provider’s subjective interpretation of patient’s 
condition, and does not address the essential components of physical assessment. 
The fifth recommendation is to develop policy and procedure with respect to 
follow up of positive heart failure screening tool findings. Because of the multitude of 
different providers involved in patient’s care, it is often difficult to ascertain who is most 
responsible or most appropriate to address the heart failure symptoms. A proposed 
decision tree for HCPs who find positive results on the screening tool is included in 
Appendix K. 
Strengths and Limitations of the Project 
 One of the limitation of the project was that it included only patients who had a 
CRT-D or CRT-P device, as they have a known and documented history of heart failure 
(an initial indication for the implantable cardiac device). However, there may be other 
patients with an implantable cardiac device such as Permanent Pace Maker (PPM) or 
56 
 
Implantable Cardioverter Defibrillator (ICD) who may exhibit initial or ongoing signs 
and symptoms of heart failure and who have not been included in the screening.  
 Another limitation of the project was the fact that the HCPs were not ready for 
this practice change, as evidenced by the lack of documentation of the questionnaires, or 
its outcomes, in the patient’s clinic chart by the HCPs. As McEntee, Cuomo, and 
Dennison (2009) contended, barriers to adherence to guidelines at the provider level are 
often related to practice environment constraints, time limitations, attitudes and beliefs 
of those involved, as well as the provider’s level of knowledge of guidelines, and his/her 
comfort with recommended treatment.  
 One of the strengths of this project was that the tools contributed to an additional 
knowledge of the patient’s status/condition. For example, the provider’s review of the 
patient’s self-reported symptoms, may have provided the opportunity in offering 
additional information that may perhaps not be normally elicited during a typical patient 
encounter. This information could have altered the course of treatment or therapy.  
 Secondly, this type of screening can be applied in instances/settings where time 
resources are limited, and therefore self-report of symptoms can avert addition of extra 
resources required to collect the information. This type of screening tool therefore, is 
versatile and universal, and subsequently, can be applied in other like-settings. 
 Finally, the strength of the project is the fact that it specifically addresses nursing 
practice and contributes to further professional knowledge. As such, nurses in other 
specialties can apply this project’s findings in their own areas of practice or draw on the 
finding to implement their own projects.  
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Recommendations for Future Projects 
 One of the main recommendations for similar future projects is to actively 
involve the clinic staff in the development and evaluation of the project through small 
steps approach in order to maintain the momentum, and to retain their interest and 
enthusiasm. 
 Secondly, the value and the significance of having the relevant and applicable 
background education on the disease being assessed (heart failure), cannot be 
underestimated. Without the basic knowledge of the pathophysiology of the disease, its 
prevalence, incidence, prevailing signs and symptoms, it may be difficult for the 
HPCs/stakeholders to understand why screening is important. 
 Thirdly, it is important to ensure that the time elapsed between project design and 
implementation is short. As mentioned above, some of the staff’s interest in the project 
declined over time, and it was difficult to re-engage them. 
 Fourthly, it is crucial that the researcher is familiar and comfortable with the 
different research methodologies and approaches, even prior to determination of study 
goals and objectives. Knowing what to look for (outcomes), and how to look for it 
(methods) can make a significant difference. This knowledge plays an especially 
important role in the interpretation of findings. 
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Section 5: Dissemination Plan 
Dissemination Plan 
 As Forsyth et al. (2010) contended, it is crucial that all new knowledge gained 
through evidence-based projects be disseminated. According to Hampton et al. (2011) 
presenting program results/outcomes in a public forum allows for exposure of the issue to 
the greater audience which can help in raising awareness and drawing in and mobilizing 
additional support. Bringing attention to the issue at hand may not only help in obtaining 
added financial and human resources, but also in generating and guiding future policies.  
Institution Experiencing the Problem in Practice 
 In order to disseminate the results of this work to the organization in which this 
project was completed, a number of different approaches and methods will be utilized. 
 First of all, an executive summary of the project and project findings delivered to 
the senior management of the program, will identify the clinical issue/problem in question 
(as supported by organizational data), describe the methods of addressing this problem 
(project), present the outcomes/results, and list the suggested recommendations. The 
focus of this summary will be to identify strategies that will bring the changes forward, 
and to generate the necessary support needed for these strategies. Secondly, the purpose 
of this program level presentation will be to inform the administration of the current 
status of the program and the changes needed for improvement. 
 A power point presentation will be subsequently delivered to all of the 
stakeholders (including the arrhythmia clinic staff) at an arrhythmia grand rounds, and/or 
at cardiology grand rounds held on weekly basis in the organization. Through this venue, 
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the project results can inform others within the organization of the quality improvement 
work that is being done within the program. 
Broader Nursing Profession 
 With respect to the broader nursing profession, the results of the program will be 
presented in the format of scientific poster at local, provincial, and/or national nursing 
conferences. Sharing the results of the project as well as the challenges and successes, 
may help other nurses in implementing similar projects within their own clinical settings. 
One of the conferences in particular that may be most appropriate for this project’s result 
dissemination is the annual Canadian Cardiovascular Society Congress meeting which 
includes the Canadian Council of Cardiovascular Nurses (CCCN) chapter. This particular 
national association’s vision aligns with my own professional and personal goals: to 
advance “cardiovascular nursing through leadership, advocacy, research and knowledge 
translation” (CCCN, 2017). 
 Finally, submission of a manuscript to a peer-reviewed national or international 
nursing journal will help in disseminating the knowledge and ideas to a broader audience. 
A good quality professional journal with an international recognition and reputation, will 
ensure that the results are read by other nurses with a keen interest in advancing the 
nursing profession. 
Analysis of Self 
As a Scholar 
By completing the DNP program, I will achieve the terminal degree for my 
profession. However, now more than ever I realize that the learning will never end, nor 
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should it end. The journey of discovery will continue in my daily practice and I hope to 
instill this enthusiasm for learning to the nursing students I mentor, and to the nurses I 
work with. By providing leadership and role modeling to other nurses and nursing 
students through completion of this advance degree, will put me in a position where I can 
support them and offer advice. 
Completing the DNP program will also signal the realization of my life long goal. 
It will symbolize the accomplishment of a very arduous, but rewarding personal journey 
to fulfill a personal challenge I set out for myself. It will also give me the opportunity to 
prove to myself, my colleagues, my family, and my friends that I could do this. 
As the move towards DNP degree as the entry into advanced practice approaches, 
it is also imperative that as a practicing nurse practitioner, I am prepared and hold the 
necessary qualifications.  
Thirdly, completion of the DNP program will provide me with the necessary 
skills, knowledge, and competencies to contribute to the exploration of nursing practice 
issues and subsequently, to translation of applicable and relevant research findings to 
address these issues in order to advance nursing both as a profession, and as a science.  
As a Practitioner 
 According to one of the American Association of Colleges of Nursing’s (2006), 
essentials of Doctoral Education for Advanced Nursing Practice (essential II) the DNP 
program prepares its students to employ the “principles of business, finance, economics, 
and health policy to develop and implement effective plans for practice-level and/or 
system-wide practice initiatives that will improve the quality of care delivery” (p. 11). 
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Development, implementation, and evaluation of the DNP project has definitively 
prepared me to lead future projects and actively participate in continuous quality 
improvement within the organization, the program, and my profession. The DNP 
experience has given me the confidence, the knowledge and the skills as a practitioner, to 
develop further projects that will influence and affect not only individuals, groups, 
communities, and populations, but also the nursing profession. 
 As a practitioner, I will be better equipped to promote and model the use of 
evidence at patient, provider, and system levels. I will have the background to actively 
contribute to positive changes in the clinical practice. 
As a Project Developer 
 The most difficult role to play in this project was that of the project developer. It 
was very challenging to initially get the buy-in from the nursing staff, and I constantly 
struggled with ensuring that the project was implemented accordingly. Numerous email 
reminders as well as individual meetings were necessary for the project to be completed. 
 On a more positive note, as a project manager I had the opportunity to apply 
gained knowledge and skills to design, implement, and evaluate a clinical program within 
the organization on my own. The prospect of leading the entire project, rather than being 
a passive participant, was initially quite daunting. However, given that the project was 
going to influence outcomes and contribute to best care, the experience was very 
rewarding. Finally, by recommending innovative approaches to improving patient care, in 
view of the resource constraints, I felt that I was really making a difference. 
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Challenges, Solutions, and Insights 
 Overall, my experience of completing this DNP project has been a very positive 
one. There has been no major glitches, interruptions, or setback. It has been a very 
challenging but also a rewarding experience that required a tremendous physical and 
emotional commitment. However, to see the project progress from mere notions and ideas 
to a finished product, was both exciting and gratifying.   
 One of the biggest challenges of completing my DNP project was the time interval 
that was required to complete the different stages of the project, starting with the 
proposal, through the IRB process, and finally implementation and evaluation. However, 
each stage of the project was a crucial component that needed to be completed in order to 
naturally proceed to the next stage. Nevertheless, this time lag played a key role when the 
time for implementation came about. Having heard about the project months ago, the 
clinic staff forgot about the project details, and also lost some of their enthusiasm when 
the time came to implement. To address this challenge in future projects, it would be 
worthwhile to bring all of the stakeholder together again before implementation, in order 
to generate a renewed interest and enthusiasm about the project. 
 What I learned most about this scholarly journey, is that it takes a lot of time and 
planning to get things rights. In my previous experience, projects that were rushed 
through, or ones that took shortcuts, failed either before implementation, or before 
evaluation was completed.  As such, a well-designed project/study requires the ongoing 
commitment from the project leader, and continuous attention to details. 
 
63 
 
Summary 
 Heart failure continues to pose a significant burden on the society due to its 
resource-intensive requirements and resultant financial costs. As such, the need to quickly 
and effectively identify those who have heart failure or who are at risk for heart failure, is 
of the highest priority, regardless of the clinical setting. Screening tools which employ 
patient administered self-reported symptoms of heart failure questionnaires, allow for an 
efficient and effective method of identifying those at highest risk. This is especially true 
in an ADC setting where resources are limited, and the mandate does not incorporate full 
physical assessment and focused history taking into clinic visit. This doctoral project 
allowed for the examination, evaluation, and recommendation of the most appropriate and 
suitable screening tool for the ADC.  
 After a comprehensive and detailed analysis of the project data, the project leader 
concluded that the best heart failure screening tool for the ADC setting was the SHEFS 
questionnaire. It was the simplest tool to complete with the least amount of resources 
required. The tool also performed better with respect to identifying those who are more 
likely to have heart failure, when compared to the other heart screening tools such as the 
KCCQ and the MLHFQ, based on the concordance to the gold standard test for heart 
failure: the NT-proBNP blood test. As a result of these findings, a number of 
recommendations were made. 
 First of all, the project leader recommended that the SHEFS questionnaire be 
implemented as the screening tool of choice for the ADC. Secondly, that the screening for 
heart failure in the ADC become an expected standard. Thirdly, that a mandatory 
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education on heart failure be provided to all new staff members to the ADC. Fourthly, 
that a comprehensive documentation tool be implemented in place of the existing tool. 
Finally, that a policy and procedure be developed with respect to follow up care of 
patients with positive heart failure screening results. 
 The purpose of this doctoral project was to translate the knowledge, skill, and 
experience acquired through the process of designing, implementing, and evaluating a 
quality improvement project, in order to guide and direct nursing practice changes 
reflective of latest research and evidence. Ultimately, the project outcomes resulted in 
recommendations for the practice setting, as well as organizational system changes, in 
order to improve the quality of healthcare delivery whilst meeting the needs of the 
individuals and the community in question. 
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Appendix A: Heart Failure Screening Tools 
Tool/Instrument 
Name 
Description Reference 
KCCQ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KCCQ-12 
-Domains assessed: physical 
limitations, symptoms, self-efficacy, 
social limitations, quality of life 
-23 item questionnaire 
-Scoring ranges from one to seven 
(one representing severe limitations 
or high frequency of symptoms, and 
seven representing no limitations or 
rare occurrence of symptoms) 
-Maximum possible score is 150, 
with lower scores representing 
significant effect on quality of life, 
and higher score representing little or 
no effect on quality of life 
 
-12 item questionnaire 
-scoring as per KCCQ 
-Maximum possible score is 70 with 
lower scores representing significant 
effect on quality of life, and higher 
score representing little or no effect 
on quality of life 
 
Green et al., 2008 
 
 
MLHFQ -Domains assessed: physical, 
emotional 
-21 item questionnaire 
-Scoring scale ranging from zero to 
five (zero representing no limitations 
to activities and five representing 
limitations at all times) 
-Maximum possible score 105, with 
lower scores representing no effect 
on quality of life, and higher scores 
representing significant effect 
 
Rector et al., 1987 
Chronic Heart 
Failure 
Questionnaire 
-Domains assessed: dyspnea, fatigue, 
emotional 
-16 item questionnaire 
-scoring from worst to best with 
scores ranging between 16 and 112 
Guyatt et al., 1989 
82 
 
-measures longitudinal change over 
time 
Quality of Life 
Questionnaire in 
Severe Heart 
Failure 
-Domains assessed: psychological, 
physical activity, life-dissatisfaction, 
somatic symptoms 
-26 item questionnaire 
-scoring from best to worst with 
scores ranging between 0 and 130 
-self-assessment of health related 
quality of life in severe heart failure 
Wiklund et al., 1987 
Left Ventricular 
Dysfunction 
(LVD-36) 
-Domains assessed: not clear 
-36 item questionnaire 
-scoring from best to worst with 
scores ranging between 0 and 100 
-measures the impact of LVD on 
quality of daily life and overall well-
being 
O’Leary et al., 2000 
Cardiac Health 
Profile Congestive 
Heart Failure 
-Domains assessed: not clear 
-10 item visual analog scales to 
determine patient’s perception of 
how heart failure influences 
physical, psychological, and social 
well-being 
Mannheimer et al., 2007 
Chronic Heart 
Failure 
Assessment Tool 
-Domains assessed: symptoms, 
activity levels, psycho-social, 
emotions 
-46 items measured through a variety 
of scales to assess patient’s 
perspective of quality of life in heart 
failure 
Dunderdale et al., 2008 
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Appendix B: Self-Reported Heart Failure Symptoms (SHEFS) Questionnaire 
Arrhythmia Devices Clinic Questionnaire     
Please take a  few minutes to let us know how you have been feeling since we last saw you in 
our clinic: 
              YES         NO         DON’T 
                        KNOW 
 Since we last saw you, have you been more short of breath than usual? 
  
 Since we last saw you, have you had to sleep on more pillows than  
 
usual to help with your breathing?  
 
 Since we last saw you, have you been awakening at night feeling short 
of breath? 
 Since we last saw you, have your feet or abdomen been more swollen?  
 
 Since we last saw you, did you require adjustment of your water pill?  
 
 Is there anything you would like to ask about your device today? 
 
Please specify:________________________________________________ 
 
 Who looks after your heart failure, or adjusts your water pill? (please circle) 
  
Cardiologist  Family Doctor Heart Function Clinic Don’t know 
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Appendix C: Minnesota Living with Heart Failure Questionnaire (MLHFQ) 
11/10/04 
 
 
 
MINNESOTA LIVING WITH HEART FAILURE  QUESTIONNAIRE 
 
The following questions ask how much your heart failure (heart condition) affected your 
life during the past month (4 weeks).  After each question, circle the 0, 1, 2, 3, 4 or 5 to 
show how much your life was affected.  If a question does not apply to you, circle the 0 
after that question. 
 
Did your heart failure prevent  
you from living as you wanted during                        Very                            Very 
the past month (4 weeks) by -                          No      Little                 Much  
       
1.  causing swelling in your ankles or legs?           0            1        2        3        4        5 
2.  making you sit or lie down to rest during    
     the day?                    0            1        2        3        4        5 
3.  making your walking about or climbing      
     stairs difficult?                   0            1        2        3        4        5 
4.  making your working around the house    
     or yard difficult?                   0            1        2        3        4        5 
5.  making your going places away from           
     home difficult?                   0            1        2        3        4        5 
6.  making your sleeping well at night 
     difficult?                    0            1        2        3        4        5 
7.  making your relating to or doing things 
     with your friends or family difficult?                0            1        2        3        4        5 
8.  making your working to earn a living 
     difficult?                    0            1        2        3        4        5                                                               
9.  making your recreational pastimes, sports 
     or hobbies difficult?                  0            1        2        3        4        5 
10.  making your sexual activities difficult?    0            1        2        3        4        5 
11.  making you eat less of the foods you  
        like?                    0            1        2        3        4        5 
12.  making you short of breath?                 0            1        2        3        4        5 
13.  making you tired, fatigued, or low on 
       energy?                    0            1        2        3        4        5 
14.  making you stay in a hospital?     0            1        2        3        4        5 
15.  costing you money for medical care?    0            1        2        3        4        5 
16.  giving you side effects from treatments?    0            1        2        3        4        5   
17.  making you feel you are a burden to your  
       family or friends?          0            1        2        3        4        5 
18.  making you feel a loss of self-control 
        in your life?                   0            1        2        3        4        5  
19.  making you worry?                  0            1        2        3        4        5 
20.  making it difficult for you to concentrate 
        or remember things?                  0            1        2        3        4        5  
21.  making you feel depressed?                 0            1        2        3        4        5 
_________________________________________________________________________ 
 
©1986 Regents of the University of Minnesota, All rights reserved.  Do not copy or reproduce without permission. 
LIVING WITH HEART FAILURE® is a registered trademark of the Regents of the University of Minnesota. 
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Appendix D: Kansas City Cardiomyopathy Questionnaire (KCCQ) 
 
Rev. 2012-04-11 
Kansas City Cardiomyopathy Questionnaire (KCCQ-12) 
 
The following questions refer to your heart failure and how it may affect your life. Please read and complete the following 
questions. There are no right or wrong answers. Please mark the answer that best applies to you. 
 
1. Heart failure affects different people in different ways. Some feel shortness of breath while others feel fatigue. Please 
indicate how much you are limited by heart failure (shortness of breath or fatigue) in your ability to do the following 
activities over the past 2 weeks. 
Activity 
Extremely 
Limited 
Quite a bit 
Limited 
Moderately 
Limited 
Slightly 
Limited 
Not at all 
Limited 
Limited for 
other reasons 
or did not do 
the activity 
a. Showering/bathing O O O O O O 
b. Walking 1 block on 
level ground O O O O O O 
c. Hurrying or jogging 
(as if to catch a bus) O O O O O O 
 1 2 3 4 5 6 
 
2. Over the past 2 weeks, how many times did you have swelling in your feet, ankles or legs when you woke up in the 
morning? 
Every morning 
3 or more times 
per week but 
not every day 1-2 times per week 
Less than 
once a week 
Never over the 
past 2 weeks 
O O O O O 
  
 1 2 3 4 5  
  
3. Over the past 2 weeks, on average, how many times has fatigue limited your ability to do what you wanted? 
 
All of 
the time 
Several times 
per day 
At least 
once a day 
3 or more times 
per week but 
not every day 
1-2 times 
per week 
Less than 
once a week 
Never over the 
past 2 weeks 
O O O O O O O 
 
 1 2 3 4 5 6 7 
  
4. Over the past 2 weeks, on average, how many times has shortness of breath limited your ability to do what you 
wanted? 
All of 
the time 
Several times 
per day 
At least 
once a day 
3 or more times 
per week but 
not every day 
1-2 times 
per week 
Less than 
once a week 
Never over the 
past 2 weeks 
O O O O O O O 
 
 1 2 3 4 5 6 7 
  
5. Over the past 2 weeks, on average, how many times have you been forced to sleep sitting up in a chair or with at 
least 3 pillows to prop you up because of shortness of breath? 
 
Every night 
3 or more times 
per week but 
not every day 
1-2 times 
per week 
Less than 
once a week 
Never over the 
past 2 weeks 
O O O O O 
 
 1 2 3 4 5 
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KCCQ-12 
Page 2 of 2 
 
 
Rev. 2012-04-16 
6. Over the past 2 weeks, how much has your heart failure limited your enjoyment of life? 
 
It has extremely 
limited my enjoyment 
of life 
It has limited my 
enjoyment of life 
quite a bit 
It has moderately 
limited my enjoyment 
of life 
It has slightly 
limited my enjoyment 
of life 
It has not limited 
my enjoyment 
of life at all 
O O O O O 
 
 1 2 3 4 5 
 
 
7. If you had to spend the rest of your life with your heart failure the way it is right now, how would you feel about this? 
 
Not at all 
satisfied 
Mostly 
dissatisfied 
Somewhat 
satisfied 
Mostly 
satisfied 
Completely 
satisfied 
O O O O O 
 
 1 2 3 4 5 
 
 
8. How much does your heart failure affect your lifestyle? Please indicate how your heart failure may have limited your 
participation in the following activities over the past 2 weeks. 
 
Activity 
Severely 
Limited 
Limited 
quite a bit 
Moderately 
limited 
Slightly 
limited 
Did not 
limit at all 
Does not apply 
or did not do for 
other reasons 
a. Hobbies, recreational 
activities O O O O O O 
b. Working or doing 
household chores O O O O O O 
c. Visiting family or 
friends out of your 
home 
O O O O O O 
 1 2 3 4 5 6 
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Appendix E: Cover Letter for Patients 
Arrhythmia Devices Clinic 
 
Dear patient: 
 
We are continuously finding new ways to improve the 
quality of care we provide to our patients, such as you. 
As part of this quality improvement process, we would 
like to ask you to complete the attached questionnaires 
while you are waiting for your appointment with our 
clinic staff.  
 
The purpose of these questionnaires is to help us 
identify any changes in your health as it relates to your 
visit today.   
 
There are three questionnaires. Once you complete 
them, please give the package to one of the health care 
providers you see during your appointment. 
Thank you, 
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Appendix F: Literature Review Matrix 
 
Summary Table of Analyzed Articles 
Citation (in APA style 
with doi or link) 
Conceptual 
Framework / 
Theory 
Main finding Research 
method / 
Sample size / 
Strengths of 
the study 
Weaknesses 
of the study 
Level of 
Evidence 
Guyatt, G. H. (1993). 
Measurement of health-
related quality of life in 
heart failure. Journal of 
American College of 
Cardiology, 22(4 Suppl 
A), 185A-191A. 
 
Not identified 
/not used 
Only MLHFQ 
showed disease-
specific 
responsiveness 
in context of 
clinical trials. 
Descriptive 
method 
utilized. No 
sample size 
identified. 
Description of 
generic and 
specific 
approaches to 
measuring 
quality of life 
were outlined. 
An example of 
disease-
specific 
measures in 
heart failure 
was provided. 
 
Comparison of 
different 
questionnaires 
based only on 
outcomes of 
single studies. 
VI 
Guyatt, G. H. (1995). A 
taxonomy of health 
status instruments. 
Journal of 
Rheumatology, 22(6), 
1188-1190. 
 
Not identified 
/not used 
Health related 
quality of life 
questionnaires 
should be used 
to inform care 
and guide 
policy 
development. 
There are 
Descriptive 
method 
utilized. No 
sample size 
identified. 
A taxonomy of 
different 
instruments 
was listed—
generic and 
specific--
which 
provided the 
reader with 
Listing of all 
of the 
available 
instruments 
but no 
comparison 
between the 
instruments. 
VII 
89 
 
generic 
instruments and 
specific 
instruments—
each has 
strengths and 
weakness. 
Depending on 
the focus, one 
may be better 
over the other. 
 
 
 
options as to 
what is 
available. 
Berry, C., & 
McMurray, J. (1999). 
A review of quality-of-
life evaluations in 
patients with 
congestive heart 
failure. 
Pharmacoeconomics, 
16(3), 247-271. 
 
Not identified 
/not used 
 
Best disease-
specific QOL 
questionnaires 
are the MLHFQ 
and the CHFQ. 
Review of the 
design and 
validation 
process of 
generic and 
disease 
specific 
quality of life 
(QOL) 
questionnaires. 
Detailed 
description of 
the various 
elements 
measuring the 
instruments’ 
validity and 
ability to 
discriminate 
between 
changing 
levels of 
severity of the 
disease.  
 
 
Conclusions 
were drawn 
based on 
results of 
single studies 
only.  
 
VI 
90 
 
Eurich, D. T., Johnson, 
J. A., Reid, K. J., & 
Spertus, J. A. (2006). 
Assessing 
responsiveness of 
generic and specific 
health related quality of 
life measures in heart 
failure. Health and 
Quality of Life 
Outcomes, 4(89). 
http://doi.org/10.1186/1
477-7525-4-89 
 
Not identified 
/not used 
 
KCCQ was the 
most responsive 
health quality of 
life 
questionnaire to 
assess change 
over a 6-week 
period of time 
Cohort study 
design with 
sample size of 
298 subjects 
with heart 
failure. Three 
different 
questionnaires 
were 
administered 
and patients’ 
change was 
measured 
using three 
external 
indicators. 
 
Subjects were 
recruited from 
14 medical 
centers across 
Canada and 
the United 
States (allows 
for 
generalizabilit
y) 
Some of the 
external 
indicators used 
to measure 
change are 
subjective 
(NYHA class). 
Small sample 
size. 
Unclear as to 
sampling 
method: 
possible 
sampling bias? 
VI 
Garin, O., Ferrer, M., 
Pont, A., Rue, M., 
Kotzeva, A., Van 
Ganse, E., & Alonso, J. 
(2009). Disease-
specific health-related 
quality of life 
questionnaires for heart 
failure: A systematic 
review with meta-
analyses. Quality of 
Life Research, 18(1), 
71-85. http:// 
Not identified 
/not used 
 
Evidence 
showed that the 
MLHFQ was 
most reliable, 
valid, and 
responsive tool 
among those 
tested, followed 
by the KCCQ, 
then CHFQ. 
Systematic 
review with 
meta-analysis. 
Full text 
reviews were 
performed on 
421 studies. 
High level of 
evidence and 
large sample 
size. 
The study 
tested for the 
most 
important/desir
able 
components in 
a clinical tool: 
reliability, 
validity, and 
Did not 
address the 
administrative 
burden on the 
patients when 
completing the 
questionnaires. 
Study did not 
identify the 
effect of the 
different 
settings 
(hospital, 
I 
91 
 
doi.org/10.1007/s11136
-008-9416-4 
 
responsiveness
. 
clinic, etc.). 
Garin, O., Ferer, M., 
Pont, A., Wiklund, I., 
Van Ganse, E., Vilagut, 
G., …Alonso, J. 
(2013). Evidence on 
the global measurement 
model of the Minnesota 
Living with Heart 
Failure Questionnaire. 
Quality of Life 
Research, 22(1), 2675-
2684. http:// 
doi.org/10.1007/s11136
-013-0383-z 
 
Not identified 
/not used 
 
The total 
MLFHQ score 
was the most 
commonly used 
score in heart 
failure patients. 
Merged data 
from eight 
studies and 21 
countries. 
Sample size: 
3847 patients. 
The reliability 
and validity of 
the MLHFQ 
was shown to 
be consistent 
among 
different 
countries. 
The 
effectiveness 
of the 
instruments 
was evaluated 
using different 
criteria/ 
elements 
among the 
different 
countries.  
VI 
Garin, O., Herdman, 
M., Vilagut, G., Ferre, 
M., Ribera, A., Rajmil, 
L., …Alonso, J. (2014). 
Assessing health-
related quality of life in 
patients with heart 
failure: A systematic, 
standardized 
comparison of 
available measures. 
Heart Failure Reviews, 
Not identified 
/not used 
The instruments 
identified as 
best with 
respect to 
reliability, 
validity, 
sensitivity, and 
interpretability 
were: KCCQ 
and MLHFQ. 
Systematic 
review of all 
of the 
available 
health-related 
quality of life 
instruments. 
Seven tools 
were identified 
specifically for 
heart failure. 
Each of the 
heart failure 
questionnaires 
were evaluated 
based on 
several 
different 
aspects such 
as: validity, 
sensitivity, 
reliability, and 
interpretability 
None 
identified. 
I 
92 
 
19(3), 359-367. http:// 
doi.org/10.1007/s10741
-013-9394-7 
 
Kelkar, A. A., Spertus, 
J., Pang, P., Pierson, R. 
F., Cody, R. J., Pina, I. 
L., …Butler, J. (2016). 
Utility of patient-
reported outcome 
instruments in heart 
failure. Journal of 
American College of 
Cardiology, 4(3), 165-
175. http:// 
doi.org/10.1016/j.jchf.2
015.10.015 
 
Not identified 
/not used 
 
Only two 
patient-reported 
outcome (PRO) 
instruments for 
heart failure 
met the study 
evaluation 
criteria: KCCQ 
and MLHFQ. 
A systematic 
review of 
research 
studies that 
measured PRO 
instruments in 
heart failure. 
31 instruments 
were 
identified, and 
nine met all 
inclusion 
criteria, and 
two met all 
evaluation 
criteria. 
The study used 
detailed 
criteria for 
measuring the 
properties of 
the PROs. 
The study did 
not examine 
the efficiency 
of 
implementing 
/administering 
these 
questionnaires. 
Therefore, 
unable to 
evaluate 
feasibility of 
applying these 
instruments in 
clinical 
practice of 
varying 
settings. 
 
I 
Gilbert, A., Sebag-
Montefiore, D., 
Davidson, S., & 
Velikova, G. (2015). 
Use of patient-reported 
outcomes to measure 
symptoms and health 
Not identified 
/not used 
Clinical care 
may benefit 
from integration 
of 
patient-
reported-
outcomes 
Review of 
other articles 
utilizing 
patient-
reported-
outcomes 
(PROs). No 
The benefits of 
using PROs 
are identified, 
including 
frequency and 
timing of 
administration. 
Not a 
systematic 
review of data. 
Only case 
studies 
presented.  
IV 
93 
 
related quality of life in 
the clinic. Gynecologic 
Oncology, 136(2015), 
429-439. http:// 
doi.org/10.1016/j.ygyn
o.2014.11.071 
 
(PROs) 
instruments in 
assessments.  
sample size 
available, no 
method 
identified. 
The best 
methods of 
collecting this 
data is 
proposed.  
Spertus, J. A., & 
Nassif, M. E. (2016). 
Screening health 
questionnaires and 
patient-reported 
outcomes: Will 
shortened versions 
overcome the barriers 
to their 
implementation. 
Journal of Cardiac 
Failure, 22(2), 
1080109. http:// 
doi.org/10.1016/j.cardf
ail.2015.11.010 
 
Not identified 
/not used 
Shortened 
versions of 
screening 
instruments 
may under-
report or under-
recognize 
significance of 
symptoms. 
No specific 
method or 
sample size 
identified. 
Highlights the 
importance of 
inclusive 
assessment of 
all aspect/ 
components of 
the patient’s 
status 
including 
cognitive 
status.  
Opinion only. 
No specific 
data was 
presented. 
VII 
Psotka, M. A., von 
Maltzahn, R., 
Anatchkova, M., 
Agodoa, I., Chau, D., 
Malik, F. I., … 
Teerlink, J. R. (2016). 
Patient-reported 
Not identified 
/not used 
None of the 
chronic heart 
failure patient-
reported 
outcome (PRO) 
instruments met 
the FDA 
A systematic 
literature 
review of all 
of the 
available 
articles 
identifying the 
Exhaustive 
literature 
review of all 
available 
articles over 
the span of 
five years 
Only the 
PROs that met 
the FDA 
recommended 
guidelines 
were reviewed 
and analyzed. 
I 
94 
 
outcomes in chronic 
heart failure: 
Applicability for 
regulatory approval. 
Journal of American 
Colleges of Cardiology, 
4(10), 791-804. http:// 
doi.org/10.1016/j.jchf.2
016.04.010 
 
recommended 
guidelines. 
use of PROs. 
2,552 articles 
and 2,334 
abstracts were 
identified. 19 
were chosen 
for review. 
(inclusive-
ness). 
Heidenreich, P. A., 
Spertus, J. A., Jones, P. 
G., Weintraub, W. S., 
Rumsfeld, J. S., 
Rathore, S. S., 
…Williams, R. E. 
(2006). Health status 
identifies heart failure 
outpatients at risk for 
hospitalization or 
death. Journal of 
American College of 
Cardiology, 47(7), 752-
756. http:// 
doi.org/10.1016/j.jacc.2
005.11.021 
 
Not 
identified/not 
used 
 A low score 
obtained on 
Kansas City 
Cardio-
myopathy 
Questionnaire 
(KCCQ) was 
association with 
a poor 
prognosis for 
patients with 
heart failure.  
The sample 
size consisted 
of 505 patients 
with heart 
failure, from 
13 outpatient 
clinics. 
Consecutive 
patients who 
met the study 
criteria were 
included 
(ejection 
fraction 
<40%). 
The sensitivity 
of a tool 
(independent 
of other 
clinical data) 
was utilized to 
predict heart 
failure 
prognosis. 
Only one 
questionnaire 
was used 
(KCCQ) to 
evaluate for 
predictors of 
prognosis 
independent of 
other clinical 
data. 
III 
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Appendix G: Levels of Evidence 
 
Level of 
Evidence 
Description 
 
I 
 
Evidence from a systematic review or meta-analysis of all relevant 
RCTs  
II 
 
Evidence obtained from well-designed RTC. 
III 
 
Evidence obtained from well-designed controlled trials without 
randomization 
IV 
 
Evidence from well-designed case-control and cohort studies 
V 
 
Evidence from systematic reviews of descriptive and qualitative studies 
VI Evidence from single descriptive or qualitative studies 
 
VII Evidence from the opinion of authorities and/or reports of expert 
committees 
 
 
Ackley, B. J., Swan, B. A., Ladwig, G., & Tucker, S. (2008). Evidence-based nursing 
care guidelines: Medical-surgical interventions. (p. 7). St. Louis, MO: Mosby Elsevier. 
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Appendix H: Research Ethics Board Approval 
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Appendix I: IRB Approval  
 
From:	IRB	<irb@mail.waldenu.edu>	
Sent:	Friday,	May	26,	2017	4:54	PM	
To:	Lucy	Paul	
Cc:	Patrick	A.	Palmieri	
Subject:	IRB	Materials	Approved	-	Lucy	Paul	
		
Dear Ms. Paul, 
  
This email is to notify you that the Institutional Review Board (IRB) confirms that 
your study entitled, "Heart Failure Screening Tools: Assessment for an 
Outpatient Arrhythmia Devices Clinic," meets Walden University’s ethical 
standards. Our records indicate that you will be analyzing data provided to you 
by Hamilton Health Sciences as collected under its oversight. Since this study 
will serve as a Walden doctoral capstone, the Walden IRB will oversee your 
capstone data analysis and results reporting. The IRB approval number for this 
study is 05-26-17-0542764. 
  
This confirmation is contingent upon your adherence to the exact procedures 
described in the final version of the documents that have been submitted 
to IRB@mail.waldenu.edu as of this date. This includes maintaining your current 
status with the university and the oversight relationship is only valid while you are 
an actively enrolled student at Walden University. If you need to take a leave of 
absence or are otherwise unable to remain actively enrolled, this is suspended. 
  
If you need to make any changes to your research staff or procedures, you must 
obtain IRB approval by submitting the IRB Request for Change in Procedures 
Form.  You will receive confirmation with a status update of the request within 1 
week of submitting the change request form and are not permitted to implement 
changes prior to receiving approval.  Please note that Walden University does 
not accept responsibility or liability for research activities conducted without the 
IRB's approval, and the University will not accept or grant credit for student work 
that fails to comply with the policies and procedures related to ethical standards 
in research. 
  
When you submitted your IRB materials, you made a commitment to 
communicate both discrete adverse events and general problems to the IRB 
within 1 week of their occurrence/realization.  Failure to do so may result in 
invalidation of data, loss of academic credit, and/or loss of legal protections 
otherwise available to the researcher. 
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Both the Adverse Event Reporting form and Request for Change in Procedures 
form can be obtained at the IRB section of the Walden 
website:http://academicguides.waldenu.edu/researchcenter/orec 
  
Researchers are expected to keep detailed records of their research activities 
(i.e., participant log sheets, completed consent forms, etc.) for the same period of 
time they retain the original data.  If, in the future, you require copies of the 
originally submitted IRB materials, you may request them from Institutional 
Review Board. 
 
Both students and faculty are invited to provide feedback on this IRB experience 
at the link below: 
  
http://www.surveymonkey.com/s.aspx?sm=qHBJzkJMUx43pZegKlmdiQ_3d
_3d 
  
Sincerely, 
Libby Munson 
Research Ethics Support Specialist 
Office of Research Ethics and Compliance 
Walden University 
100 Washington Avenue South, Suite 900 
Minneapolis, MN 55401 
Email: irb@mail.waldenu.edu 
Phone: (612) 312-1283 
Fax: (626) 605-0472 
  
Information about the Walden University Institutional Review Board, including 
instructions for application, may be found at this 
link:http://academicguides.waldenu.edu/researchcenter/orec 
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Appendix J: Comparison Between Heart Failure Screening Groups 
 
1. SHEFS, MLHFQ and KCCQ compared to BNP:     
 
     
  
 
 
Numbers 
   
Percentage  
 
 
  BNP   BNP 
 
 
  Yes No    Yes No  
 SHEFS Yes 5 1 6 83.3%  Sensitivity 
 
No 1 8 9  88.9% Specificity 
    6 9 15     
 MLHFQ Yes 2 0 2 33.3%  Sensitivity 
 
No 4 9 13  100.0% Specificity 
    6 9 15     
 KCCQ Yes 3 1 4 50.0%  Sensitivity 
 
No 3 8 11  88.9% Specificity 
    6 9 15     
 Chi square comparison:  p < 0.001 
 
2. SHEFS compared to MLHFQ:   
  
  
 
     
  
 
 
Numbers 
   
Percentage  
 
 
  MLHFQ   BNP 
 
 
  Yes No    Yes No  
 SHEFS Yes 5 13 18 71.4%  Sensitivity 
 
No 2 35 37  72.9% Specificity 
    7 48 55     
 Chi square comparison:  p < 0.001     
 
     
  
 3. SHEFS compared to KCCQ:  
  
  
 
     
  
 
 
Numbers 
   
Percentage  
 
 
  KCCQ   BNP 
 
 
  Yes No    Yes No  
 SHEFS Yes 6 12 18 75.0%  Sensitivity 
 
No 2 35 37  74.5% Specificity 
    8 47 55     
 Chi square comparison:  p < 0.001 
  
  
 
100 
 
 
4. Univariate regression analysis of SHEFS, KCCQ, MLHFQ and BNP, and admission to 
hospital in last 6 months  
 
 
Dependent variable = Admission to hospital   
 
     
  
 
 
  p value 
  
  
 
 
SHEFS 0.023 
  
  
 
 
MLHFQ 0.030 
  
  
 
 
KCCQ 0.025 
  
  
 
 
BNP 0.310 
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Appendix K: Decision Tree for Follow Up of Positive Screening Results 
 
